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EXPLORATION OF THERMODYNAMIC AND STRUCTURAL CHANGES  
RELEVANT TO THE ALLOSTERIC INHIBITION IN PHOSPHOFRUCTOKINASE 




Phosphofructokinase from Bacillus stearothermophilus (BsPFK) and 
Escherichia coli (EcPFK) are allosterically inhibited by downstream glycolytic pathway intermediate phosphoenol-pyruvate (PEP). The coupling free energy, 
∆𝐺𝐺𝑎𝑎𝑎𝑎, describes the interaction between substrate, Fru-6-P, and PEP. Positive for inhibition, ∆𝐺𝐺𝑎𝑎𝑎𝑎  is the standard free energy for the following disproportionation equilibrium: PEP:PFK + PFK:Fru-6-P ⟷ PFK + PEP:PFK:Fru-6-P and quantitatively expresses the nature and magnitude of the allosteric effect. This reaction provides the key to understanding why ∆𝐺𝐺𝑎𝑎𝑎𝑎 achieves its particular value. For EcPFK, the larger positive enthalpy term determines the positive sign for ∆𝐺𝐺𝑎𝑎𝑎𝑎. In BsPFK both components are negative, and the larger absolute value of the entropy term drives inhibition, suggesting fundamentally different mechanisms may transfer the allosteric signal between PEP and Fru-6-P binding sites. In this body of work, BsPFK and EcPFK structures are perturbed by both urea and engineered “holes”, and the effect on the poise of the equilibrium in response is examined. Methyl-TROSY NMR was also used to obtain structural information on all four species of BsPFK that contribute to the equilibrium. Both activity and ∆𝐺𝐺𝑎𝑎𝑎𝑎  increase at low urea concentrations for BsPFK, but not for EcPFK. Van’t Hoff analysis on BsPFK indicates that the absolute values for 
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 both the entropy and enthalpy components of ∆𝐺𝐺𝑎𝑎𝑎𝑎 change, and that the increase in allosteric coupling results from a larger change in entropy. Two of the three hole mutations had significant, but opposite, effects on the coupling. A 4-fold augmentation of coupling was seen for I153V-BsPFK, and the larger effect was determined to be on the enthalpy component. An analogous mutation in EcPFK, L154V, served as a control and had a minimal effect on the coupling. Methyl-TROSY NMR was used to probe structural changes throughout BsPFK related to allosteric coupling, and it was shown that there is not likely a discrete pathway involved in the propagation of the allosteric signal. Instead, residues throughout the enzyme are identified as contributors to the allosteric coupling. Together with the urea and hole mutant results we paint a picture of allosteric coupling in BsPFK that involves global changes in both the conformation entropy and structure. 
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 CHAPTER I 
INTRODUCTION: A HISTORY OF ALLOSTERIC THEORY AND THE DYNAMICS OF 
ALLOSTERIC ENZYMES  Living cells do not synthesize or breakdown more material than what is required for their metabolism and growth. Functioning at this remarkable level of efficiency necessitates precise control mechanisms for the turning on and off of metabolic reactions. Enzyme catalysts play a major role in the regulation of metabolic processes by immensely accelerating the rates of specific biochemical reactions. The benefit of an enzymatic catalyst, in contrast to an inorganic catalyst, is that enzyme activity can be regulated. Regulation of an enzyme can be accomplished by altering either its synthesis or catalytic activity. The magnitude of enzyme synthesis is modified by interfering with either the transcription that forms mRNA or the translation of the mRNA into protein. In prokaryotic cells transcription can be activated or inhibited when the function of RNA polymerase is altered due to the binding of a regulatory transcription factor and/or other protein to DNA. Bacteria often regulate translation by producing specific antisense RNA that is complementary to the mRNA that codes for synthesis of the enzyme. When the complementary antisense RNA binds to the mRNA it can no longer be translated into protein and the enzyme is not synthesized.  
1 
 
 The regulation of enzyme activity can be achieved in a variety of ways including a change in pH, substrate availability, product inhibition, protein-protein interactions, covalent modification and allosteric effects. A change in pH, which can occur alongside some metabolic processes, may alter either the global conformation of the enzyme and/or the protonation state of a specific key amino acid side chain. These effects on the enzyme can result in a change in its activity. Substrate availability refers the cellular concentration of substrate available to the enzyme for turnover. If the concentration of substrate is much lower than the Km the enzyme activity will be low. If the substrate concentration is much higher than Km the active site will be saturated and the activity will be maximal. Sometimes a reaction product is structurally similar enough to the substrate that it can compete for binding at the enzyme’s active site in a phenomenon termed product inhibition. Enzymes may be phosphorylated, acetylated, methylated, sulfated, glycosylated, amidated, hydroxylated, prenylated, myristoylated, or ubiquitinated. Many of these post-translational covalent modifications are reversible. Some of the ways that these modifications can affect enzyme activity are by inducing changes in the local or global shape of the enzyme and/or by activating or inhibiting binding interactions. Non-covalent interactions between an enzyme and another protein can also alter the activity of the enzyme. Allosteric regulation of enzyme activity, either activation or inhibition, is the result of the binding of an effector small molecule(s) or protein to a site distinct from the substrate binding site. 
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 Enzymes poised at commitment steps in metabolic pathways are often subject to the most extensive allosteric regulation. One reason for this is that allosteric regulation is reversible. Another major advantage of allosteric regulation is that allosteric enzymes, unlike most enzymes, have ligand binding effectors that are not part of the pathways itself. The ability to adjust their rate in response to their physiological environment allows for the fine tuning of a pathway. Hence, the allosteric regulation of enzymes is particularly important in metabolic pathways such as glycolysis, Krebs cycle and other crucial and energetically expensive pathways. Given this central role that allosteric regulation plays in biochemical processes, the ability to decisively alter allosteric responses holds promise for drug design. In particular, because the binding of an allosteric effector can influence protein function, allosteric binding sites serve as potential drug targets. While the active sites of enzymes tend to be highly conserved, the evolutionary pressure on allosteric sites has been less severe1, therefore it is reasonable to assume that species selectivity can be more easily obtained when targeting allosteric sites. For example, eukaryotic and bacterial homologs may catalyze the same reaction, but have different regulatory effectors. Unfortunately, the lack of specific knowledge on how enzymes are allosterically regulated at the molecular level hinders the potential of rational drug design.    
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 Part 1: History and Theory of the Allosteric Effect 
 The study of allosteric regulation had its genesis when H. Edwin Umbarger recognized that the synthesis of L-isoleucine in Escherichia coli was regulated via a negative feedback mechanism. L-isoleucine, the end product of the biosynthetic pathway, inhibited selectively the activity of L-threonine deaminase, the first enzyme in the chain.2 Umbarger’s early observations of end-product inhibition in biochemical pathways were corroborated by Arthur Pardee’s work with the enzyme aspartate transcarbamylase, the first enzyme in the pyrimidine biosynthesis pathway.3,4 Jean-Pierre Changeux, then a junior doctoral student of Jacques Monod, confirmed Umbarger’s observations and demonstrated that various chemical treatments of L-threonine deaminase lead to the loss of its sensitivity to inhibitor L-isoleucine. In addition, he took note that the kinetics suggested a bimolecular reaction, and it appeared that L-threonine and L-isoleucine were bound at unique sites.5 At this time, it became clear that that the observed end-product inhibition could no longer be explained by a classical scheme where inhibitor and substrate molecules compete for the same binding site, instead a scheme involving distinct and non-overlapping sites was hypothesized. The word ‘allosteric’, allo- from the Greek meaning "other”, was introduced by Monod in 1961 at the conclusion of the 26th Cold Spring Harbor Symposium on Cellular Regulation Mechanisms to emphasize the unique structure of the effector and necessary existence of separate binding sites to accommodate both substrates and allosteric 
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 regulators.6 This created a key distinction between allosteric inhibition and classic competitive inhibition, which is caused by steric hindrance from a structural analogue of the substrate. In an attempt to rationalize how the binding of an inhibitor to a site other than the active site could affect the catalytic activity of an enzyme, Monod originally applied the ‘induced-fit’ model, to describe the allosteric effect, proposed a few years earlier by Daniel Koshland7 to explain ligand binding during catalysis. Specifically, he suggested that the binding of the regulatory ligand at the allosteric site may induce a conformational change of the protein that modifies the active site.  It has been more than 50 years since the first model attempting to describe the mechanism of allosteric regulation was invoked, and since several models with bases in both structure and thermodynamics have been employed. Before providing a detailed discussion of the various models used to elucidate the behavior of allosteric enzymes, a few features common to most of the models need to be described. The allosteric regulation of enzymes can occur either by altering the affinity of substrate binding to the enzyme or by altering the maximum velocity at which the enzyme can catalyze the reaction, termed K-type and V-type allosteric regulation, respectively. Since most allosteric enzymes are in K-type regulation systems, including phosphofructokinase, the focus from here on is on K-type regulation and the models used to account for these types of allosteric effects.  Allosteric communication occurs between distant ligand binding sites. When the ligands are different from each other the observed effect of one ligand binding 
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 on the binding affinity of the other ligand is a heterotropic effect. When the ligands are the same as each other the analogous effect is termed homotropic. Cooperativity is a characteristic common to most oligomeric allosteric proteins, although is not required, and is limited to instances that produce non-hyperbolic binding curves. Positive cooperativity occurs when there is an increase in ligand binding affinity with increasing ligand concentration, while a decrease in ligand binding affinity with increasing ligand concentration is referred to as negative cooperativity. When no cooperativity is present the result is a hyperbolic binding profile that can be described by Michaelis-Menton kinetics in the case of an enzyme. When negative cooperativity is observed the subsequent decrease in binding affinity is characterized by a shallow slope in the binding profile. Positive cooperativity occurs when the binding of the first ligand enhances the binding affinity of the subsequent ligand, and results in a sigmoidal binding profile. The resulting non-hyperbolic ligand binding curve cannot be adequately fit by the Michaelis-Menten equation. Archibald Hill formulated what we have now come to know as a Hill plot to describe the cooperative behavior of oxygen binding to hemoglobin.8 The Hill equation is used to fit the sigmoidal binding profiles of various enzymes with cooperative binding. In the absence of a unique second ligand only the homotropic coupling contributes to the non-hyperbolic binding curve that defines cooperativity.   According to our formalism, when a unique second ligand alters the cooperativity it is termed a heterotropic effect. Heterotropic cooperativity exists in 
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 two forms: (1) heterotropically induced homotropic cooperativity and (2) subsaturating heterotropic cooperativity.9 The first class refers to an effect on the magnitude of the homotropic coupling in the presence of the second ligand. At a saturating concentration of second ligand, the cooperativity can be either increased or decreased relative to the amount of cooperativity in the absence of the second ligand. The second class of heterotropic cooperativity arises when the allosteric ligand is present at intermediate concentrations and is positive regardless of the nature of the heterotropic interaction.9-11    
The Classical MWC and KNF Models The phenomenon of allosteric regulation was formally described by Jacques Monod and François Jacob for the first time in 19616 and the first protein crystal structures of myoglobin and hemoglobin were reported only a few years earlier.12,13 In fact, the 1962 Nobel Prize in chemistry was awarded to Max Ferdinand Perutz and Sir John Cowdery Kendrew for solving the X-ray crystallography structure of hemoglobin. The dramatic appearance of protein X-ray crystallography structures greatly influenced scientific thinking about the molecular basis of biological function. It is no surprise that as the fields of protein allostery and structural biology matured in parallel that developments in one field influenced the other.14 The binding events associated with enzymatic catalysis had been traditionally described using a lock and key model of molecular recognition15, and with a new appreciation of the structural changes that can occur upon binding 
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 came its revision and the proposal of the induced fit16 and fluctuation fit17 models. At about the same time two complementary models describing allostery were proposed, namely the concerted18 and the sequential models19 (Figure 1-1).   In 1965 “A Plausible Model” on the nature of allosteric transitions was proposed by the trio of Jacques Monod, Jeffries Wyman Jr., and Jean-Pierre Changeux after analyzing more than a dozen allosteric enzyme systems. This model, which was inspired by the observation of two conformational states of deoxy- and oxyhemoglobin, became known as the concerted or MWC model.18 The MWC model   
 
Figure 1-1: Schematic diagrams of the A) concerted (MWC) and 
B) sequential (KNF) models of allosteric regulation of a 
homotetramer. For the concerted model, only one equivalent of 
inhibitor (Y) is required to bind for the enzyme to undergo the 
allosteric transition from the “R” state (circles) to the “T” state 
(squares). The sequential model, on the other hand, requires 
four equivalents of inhibitor to bind for the enzyme to be 
converted from the R state to the T state.   
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 suggests that allosteric proteins are symmetric oligomers with identical subunits. Each subunit exists in two possible conformational states, tense or “T” and relaxed or “R”, which have different affinities for ligands.18 According to the model, oligomers cannot exist in a hybrid form composed of subunits in both the T state and the R state. The basic assumption of the model is that there is a pre-existing equilibrium between these two conformational states, and when the substrate binds to the free enzyme it shifts the equilibrium to the R state in a concerted transition. This diverges from the Koshland inspired induced-fit based hypothesis Monod spoke of earlier to describe the allosteric effect, in which a conformational change induced by the interaction with the ligand leads to a structurally different state. It is because all of the subunits shift to the R state when the first ligand binds that positive cooperativity is observed as the first substrate binding event facilitates the binding of the subsequent substrates. Activators also bind to the R state, and shift the equilibrium towards the R state. In the presence of an activator, the enzyme is already in the R state, so the substrate binding profile lacks cooperativity. On the other hand, when an inhibitor binds to the enzyme, the equilibrium is shifted towards the T state in a concerted transition reducing the number of R sites available to bind substrate. Thus, when performing a substrate saturation profile at any given inhibitor concentration, positive cooperativity will be observed since the number of the competent substrate binding sites are increased as the equilibrium is shifted back towards the R state. A major shortcoming of the concerted model is its inability to explain negative 
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 cooperativity, a deficit which served as part of the motivation for the development of the sequential model. It was only a few years after the MWC model was published that D. E. Koshland Jr., G. Nemethy, and D. Filmer challenged the concerted model with a sequential hypothesis. The model they proposed became known as the KNF or sequential model.19 Akin to the MWC model, the KNF model is composed of two distinct enzyme conformations, termed the “R” or relaxed state and “T” or tense state, where substrates and activators bind to the R state and inhibitors bind to the T state through an induced fit mechanism. The sequential model differs from the concerted model in that the subunits change conformation one at a time without affecting their neighboring subunits. Thus, a hybrid form of the enzyme composed of subunits in both the T state and the R state can exist in the sequential model. The KNF model also differs in that it does not invoke a pre-existing equilibrium between the two states, but rather a conformational change occurs within the enzyme to each subunit as a result of the binding of a ligand. This conformational change can affect the conformation of the other neighboring subunit, which can alter their binding affinities. Consequentially, the KNF model allows negative cooperativity in addition to positive cooperativity to be explained, something not addressed by the MWC model. The subsequent subunits change conformation sequentially with the binding of each ligand equivalent. As a result, the complete conversion from one state to another is only achieved when all sites are bound with ligand.19 
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 The models are similar in that both employ only two conformational states of the allosteric protein, a low-affinity form and a high-affinity form. Another similarity is that an allosteric conformational change is favored when a ligand binds. A key difference between the models is that in the concerted model the bound conformations preexist at equilibrium, even in the absence of ligand. The sequential model postulates induced fit16, meaning that the bound conformations are only adopted once in the presence of ligand. Notably, the concerted model is considered more restrictive in that symmetric oligomers are required and negative cooperativity cannot be treated. More than 50 years since their inception, the MWC and KNF models are still able to explain allosteric phenomena in a multitude of molecular systems. However, in spite of the ability of these models to capture the qualitative relationship between the affinities of ligands at distinct sites, neither model provides insight into exactly how allostery works at the molecular level. An additional major shortcoming of the two-state models is that they limit themselves to the existence of the binary complexes, enzyme-substrate and enzyme-effector, and do not consider the ternary complex in the case of inhibition. The ternary complex has both substrate and effector bound at the same time, making it intuitively the most important complex to consider when modeling the allosteric effect. In addition, when one considers that allostery is a comparison of how a ligand binds in the absence and presence of a second ligand it follows that you have to consider two binding events, each involving two protein complexes. Such a comparison, 
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 involving four species as opposed to two, is required to distinguish allosteric from non-allosteric protein changes. Because of the limitations of the two-state models, it is clear that a more complete model for allosterism is needed.  
The Ensemble Allosteric Model (EAM) 
 Allosteric coupling can be understood in terms of the conformational ‘energy landscape’ of the protein in a way analogous to protein folding. After Cyrus Levinthal demonstrated that the rapid process of protein folding could not be explained by a random search for the most stable thermodynamic state, the hypothesis that there was a folding pathway was adopted.20 Experimental observations did not fit such a simplistic model and it became clear that there were multiple parallel pathways for protein folding. In the late 1990s a new vision of protein folding progressively emerged as the displacement in an energy landscape of multiple partially folded conformations. This landscape is represented as an imperfect, irregular funnel. This way of modeling protein folding also had an impact on the description of catalysis, challenging explanations based on induced-fit mechanisms. Some difficulty in mimicking induced-fit processes with artificial enzymes21 pointed toward the more general problem of reproducing the dynamics of protein behavior. People began employing a protein folding like model to describe catalysis that would account for changes in dynamics in addition to structural changes.22 According to this model, the transition from one catalytic step to the next one 
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 corresponds more to a re-equilibration between an ensemble of dynamic and structural states than to the formation of new states. What represented a minor species at one step becomes the major species at the next step, and it all happens as if the ensemble of conformational states anticipated the progression of the reaction. The same statistical description could easily be adapted to model allosteric transitions.23 In this case native states are ensembles of pre-existing populations; thus, the binding of an allosteric effector causes an equilibrium shift of pre-existing conformational states.  This theory is experimentally applied using a statistical thermodynamic formalism where the high resolution structure of the unligated state is used as a template to generate a large ensemble representing as many conformational states as possible. Then, a computer algorithm considers single amino acid substitutions to each residue in a protein and examines the effects of those perturbations on the distribution of conformational states with the goal of mapping a network of associated interactions within the protein. All of the predicted conformations of the protein are sampled according to their energies, with lower energy states sampled more often than those of higher energy. The binding of any ligand to a particular state increases how often that state is sampled, so according to the EAM allosteric ligands effectively remodel the energy landscape of allosteric proteins. Stabilities and coupling energies in allosteric enzymes are generally quite modest, which according to the EAM suggests that no single state, or set of allosteric states, will necessarily dominate the ensemble. In other words, the EAM suggests that 
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 allosteric mechanisms may be more statistical, and less deterministic, than classical models suggest. A prominent feature of the EAM is that the energy landscape can be smooth with numerous accessible conformational states in its ensemble, discrete with few states, or anything in between, with each scenario providing its own unique conformational, dynamic and biologically functional effects.24 This view is far less limiting than the concerted and sequential models proposed in the late 1960s. The MWC and KNF models are limited to oligomeric proteins and to the existence of only two different conformational states, either of which represents the ternary complex. In addition, the classical structure based allosteric models do not distinguish between changes in the protein due to the allosteric transition and the modifications in protein structure that take place during catalysis. The EAM provides one way to describe allosteric behavior that results from a change in the dynamics of the system, without any additional conformational changes.25 However, like the MWC model, the EAM is still limited to pre-existing states –just more of them. Potential unique structural and dynamic effects on the conformation of the enzyme due to the binding energy of the ligand are not accounted for.  
 
Allosteric Linkage  
  Allosteric linkage is a model free thermodynamic approach that quantifies the nature and magnitude of the allosteric response by comparing the difference in the substrate binding affinity for the enzyme in effector-free and effector-saturated 
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 forms. The central concepts of thermodynamic linkage were first presented by Jefferies Wyman Jr. in a series of papers published between 1948 and 1965 in which he proclaimed that through the study of linkage between multiple reactions within a complex molecule one could describe the function of that molecule.26-28 Shortly after collaborating with Jacques Monod and Jean-Pierre Changeux on the MWC model, Wyman published a paper describing allosteric linkage in which he related the allosteric nature of a protein to thermodynamics for the first time.29 He introduced the allosteric binding potential, which can be used to quantify the allosteric response of a protein. This binding potential quantified the allosteric response of a protein. Wyman used chemical potentials to demonstrate the principle of reciprocity, which is the fact that the binding of the effector has the same influence on the binding of the substrate as the binding of the substrate has on the binding of the effector. Gregorio Weber modified and expanded Jefferies Wyman Jr.’s linkage theory in several papers published during the 1970s. Most importantly, Weber established that allosteric linkage can be written in thermodynamic terms of free energy, and introduced the concept of coupling free energy.10,11 The advantage of examining protein-ligand interactions in terms of free energy is that the relationship between binding energies and the actual molecular forces which cause them are more evident. Gregory D. Reinhart simplified Weber’s free energy description of protein-ligand and ligand-ligand interactions by applying both the kinetic notations introduced by W. Wallace Cleland30 and the single substrate-single modifier scheme 
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 devised by C. Frieden31 enabling the description of the pertinent thermodynamic relationships in allosteric enzymes9,32,33.  The power of the allosteric linkage approach to studying allostery is in its ability to describe ligand binding in free energy terms without assuming the nature of structural changes caused by ligand. The basic principle of thermodynamic linkage is reciprocity, which is to say that the effect that substrate 𝐴𝐴 has on the binding of effector 𝑌𝑌 to the enzyme 𝐸𝐸 must equal that of 𝑌𝑌 on the binding of 𝐴𝐴 to 𝐸𝐸. The simplest allosteric kinetic mechanism can be described by the scheme shown in Figure 1-2.   
 
Figure 1-2: Schematic diagram of the simplest allosteric 
mechanism with a single substrate (A) and a single allosteric 
modifier (Y). E and P stand for enzyme and product, 
respectively. Ks represent dissociation constants and are 
defined in the text.     
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 The dissociation constant for each equilibrium in the thermodynamic box is described as follows: 
  𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 = [𝐸𝐸][𝐴𝐴][𝐸𝐸𝐴𝐴]  (1-1) 
  𝐾𝐾𝑖𝑖𝑎𝑎∞ = [𝐸𝐸𝑌𝑌][𝐴𝐴][𝑌𝑌𝐸𝐸𝐴𝐴]  (1-2) 
  𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 = [𝐸𝐸][𝑌𝑌][𝐸𝐸𝑌𝑌]  (1-3) 
  𝐾𝐾𝑖𝑖𝑎𝑎∞ = [𝐸𝐸𝐴𝐴][𝑌𝑌][𝑌𝑌𝐸𝐸𝐴𝐴]  (1-4) where 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  and 𝐾𝐾𝑖𝑖𝑎𝑎∞ represent the dissociation constants for 𝐴𝐴 in the absence of 𝑌𝑌 and in the saturating presence of 𝑌𝑌, respectively. 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  and 𝐾𝐾𝑖𝑖𝑎𝑎∞ represent the dissociation constants for 𝑌𝑌 in the absence of 𝐴𝐴 and in the saturating presence of 𝐴𝐴, respectively. The relationship between 𝐴𝐴 and 𝑌𝑌 can be described by the coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎, which gives the nature and magnitude of the allosteric effect. 
𝑄𝑄𝑎𝑎𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞    (1-5) 
𝑄𝑄𝑎𝑎𝑎𝑎 = [𝑌𝑌𝐸𝐸𝐴𝐴][𝐸𝐸][𝐸𝐸𝐴𝐴][𝑌𝑌𝐸𝐸]     (1-6) The value of 𝑄𝑄𝑎𝑎𝑎𝑎 describes the nature of the effect caused by Y. When 𝑄𝑄𝑎𝑎𝑎𝑎 > 1, 𝑌𝑌 is an activator and when 𝑄𝑄𝑎𝑎𝑎𝑎 < 1, 𝑌𝑌 is an inhibitor. When 𝑄𝑄𝑎𝑎𝑎𝑎 = 1, 𝑌𝑌 has no effect on the binding of 𝐴𝐴 to 𝐸𝐸. 𝑄𝑄𝑎𝑎𝑎𝑎 also represents the thermodynamic disproportionation equilibrium constant for the following reaction: [𝑌𝑌𝐸𝐸] + [𝐸𝐸𝐴𝐴] 𝑄𝑄𝑎𝑎𝑎𝑎��  [𝐸𝐸] + [𝑌𝑌𝐸𝐸𝐴𝐴]     (1-7) 
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 Understanding the basis for the allosteric effect requires one to understand why the disproportion equilibrium achieves its particular value. Since 𝑄𝑄𝑎𝑎𝑎𝑎  is a thermodynamic parameter, the equilibrium constant is related to the coupling free energy by the following equation: 
∆𝐺𝐺𝑎𝑎𝑎𝑎 = −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅�𝑄𝑄𝑎𝑎𝑎𝑎�      (1-8) Correspondingly, inhibition has a positive coupling free energy (∆𝐺𝐺𝑎𝑎𝑎𝑎 > 0), activation has a negative coupling free energy (∆𝐺𝐺𝑎𝑎𝑎𝑎 < 0), and a ∆𝐺𝐺𝑎𝑎𝑎𝑎 equal to zero means there is no allosteric effect. ∆𝐺𝐺𝑎𝑎𝑎𝑎 represents a standard free energy, although the superscript “0” is dropped from the designation to avoid confusion with the use of that superscript for other purposes in notation.32  The rate equation for the mechanism shown in Figure 1-2 can be written as shown below as long as the substrate is assumed to achieve rapid equilibrium during the steady-state32,34: 
𝑣𝑣[𝐸𝐸]𝑡𝑡 = 𝑉𝑉𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 [𝐴𝐴] + 𝑄𝑄𝑎𝑎𝑎𝑎𝑊𝑊𝑎𝑎𝑎𝑎[𝐴𝐴][𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 [𝑌𝑌] + 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 [𝐴𝐴] + 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 [𝑌𝑌] + 𝑄𝑄𝑎𝑎𝑎𝑎[𝐴𝐴][𝑌𝑌]       (1-9) where 𝑣𝑣 is the initial velocity, and 𝑉𝑉𝑜𝑜 is the maximal activity in the absence of 𝑌𝑌. 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for substrate 𝐴𝐴 in the absence of effector 𝑌𝑌, and 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for effector 𝑌𝑌 in the absence of substrate 𝐴𝐴. 𝑊𝑊𝑎𝑎𝑎𝑎 is the ratio of 𝑉𝑉∞/𝑉𝑉𝑜𝑜, where 𝑉𝑉∞is the maximal activity in the presence of a saturating concentration of effector 𝑌𝑌. When the maximal activity is affected by the allosteric ligand 𝑊𝑊𝑎𝑎𝑎𝑎will not be equal to 1. 
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 Experimentally the coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎, can be obtained by determining the apparent dissociation constants for the substrate 𝐴𝐴 as a function of effector concentration and can be graphically depicted for 𝑌𝑌 being either an inhibitor (Figure 1-3) or an activator.35 𝑄𝑄𝑎𝑎𝑎𝑎 is represented as the ratio between the two   
 
Figure 1-3: Graphical representation of the allosteric coupling, 
𝑸𝑸𝒂𝒂𝒂𝒂, between substrate (A) and inhibitor (Y).  
  plateaus, 𝐾𝐾𝑖𝑖𝑎𝑎∞ and 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 . The dependence of the apparent dissociation constant of substrate, 𝐾𝐾𝑎𝑎   , on the effector concentration can be determined by the following equation: 
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝑌𝑌]�      (1-10) 
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 Although no cooperativity is predicted by eq 1-9 and Figure 1-2, eq 1-10 can still be applied to an oligomeric protein, like EcPFK.32 The Hill equation can be utilized to describe the degree of saturation for an oligomeric protein as a function of ligand concentration. The apparent dissociation constant for substrate, 𝐾𝐾𝑎𝑎, is the concentration at which the velocity is at half maximum and is described by the Hill equation8: 
𝑣𝑣[𝐸𝐸]𝑡𝑡 = 𝑘𝑘𝑐𝑐𝑎𝑎𝑡𝑡[𝐴𝐴]𝑛𝑛𝐻𝐻𝐾𝐾𝑎𝑎𝑛𝑛𝐻𝐻 + [𝐴𝐴]𝑛𝑛𝐻𝐻         (1-11) where 𝑣𝑣 is the rate of the reaction, [𝐸𝐸]𝑡𝑡  is total concentration of enzyme active sites, 
𝑘𝑘𝑐𝑐𝑎𝑎𝑡𝑡  is the turnover number and 𝑅𝑅𝐻𝐻  is the Hill number that depicts cooperativity in substrate binding. Since the assumption of infinite cooperativity is physically impossible, 𝑅𝑅𝐻𝐻  must be considered not as a number of subunits per protein, but rather as a measurement of the degree of cooperativity among interacting ligand-binding sites. When 𝑅𝑅𝐻𝐻  = 1, there is no cooperativity and the binding curve should fit according to Michaelis-Menten kinetics. However, when 𝑅𝑅𝐻𝐻  > 1, positive cooperativity is observed and when 𝑅𝑅𝐻𝐻  < 1 negative cooperativity is obtained.  The Hill number can be related to the allosteric coupling constant between substrate binding events in a dimer using the following equation9:  
𝑅𝑅𝐻𝐻 = 2(𝑄𝑄𝑎𝑎𝑎𝑎)1/21 + (𝑄𝑄𝑎𝑎𝑎𝑎)1/2   (1-12)  where 𝑄𝑄𝑎𝑎𝑎𝑎 is the coupling between the binding of the two substrate molecules in a dimer. Upon inspection of this equation one can determine that the Hill coefficient 
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 resulting from ligand-ligand couplings in a dimer has an upper limit of 2 and a lower limit of 0. These limits are only achieved as the coupling constants approach infinity and 0, respectively. A unifying aspect of the allosteric linkage and EAM is that an explicit structural basis for the allosteric coupling is not required: only the magnitude and sign of the coupling free energy matter. Cooper and Dryden theoretically described in a classic paper almost 30 years ago the possibility of allostery being manifested without structural change.36 The practical implication is that an understanding of the determinants of allostery does not rely upon an inspection of the bonds that are made and lost in the average structure. Indeed, since that pioneering work, numerous examples have emerged that clearly demonstrate the need for allosteric descriptions that are independent of structural change. For example, direct confirmation of allostery without a conformational change37, allostery in the absence of a structural pathway38-40, negative cooperativity41, entropy driven allosteric coupling35,42-44, allosteric changes from surface mutations that do not affect structure45,46, and allosteric communication facilitated by intrinsically disordered proteins41 are all examples of allosteric phenomena that are difficult, if not impossible, to rationalize in the context of static structural changes alone. Another puzzling example is when an allosteric ligand elicits agonistic effects under some conditions and antagonistic effects under others while binding to the same site.  
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 Never the less, the EAM is based on the same selective origins as the classical MWC model. Specifically, the ligands do not induce the formation of new conformational states, but select one state among the ensemble of pre-existing ones and ignores the energy input to the system by ligand binding. This limitation of pre-existing conformations does not exist in allosteric linkage, which describes the allosteric regulation in terms of the energetics. Therefore, potential unique structural and dynamic effects on the conformation of the enzyme due to the binding energy of the ligand are accounted for only by allosteric linkage.  
Part 2: The Study of Dynamic Allosteric Systems and Large Allosteric Systems 
 A fundamental unanswered question in field of allostery is how perturbation due to ligand binding at one site is transmitted through the protein to remote sites to effect ligand binding or enzymatic activity regulation. The early crystallographic work on allosteric systems helped to advance and establish a purely mechanical view of allosteric regulation. In recent years our understanding of allostery has shifted from a solely structural view to the current one calling for both structural and dynamic changes to be considered as potential routes for the propagation of the allosteric signal. Allostery is fundamentally thermodynamic in nature, and transmission of the allosteric signal through the protein can be mediated not only by changes in the mean conformation but also by changes in the internal motions about the mean conformation. In other words, there can be an enthalpic 
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 contribution, an entropic contribution or a combination of both effects to the allosteric coupling free energy. In their 1984 classic paper “Allostery without conformation change”, Cooper and Dryden demonstrated for the first time how long range interactions between ligand binding sites on a macromolecule could be produced by purely dynamic processes even in the absence of any conformational change.36 They propose that the effect arises out of the possible changes in frequencies and amplitudes of macromolecular thermal fluctuations in response to ligand binding, and can involve all forms of dynamic behavior, ranging from highly correlated, low frequency vibrations to random local anharmonic motions of individual or groups of atoms or groups. Cooper and Dryden used the simplest case, that of an interaction between two identical sites, to estimate that allosteric coupling free energies of several kJ/mol can exist due to dynamics alone. Sure enough, their theoretical observations were followed by a growing list of examples, from which I have selected a few to describe below, to illustrate the link between dynamics over a wide range of time scales and allosteric regulation. Two scientific advances of very different natures have proven to be vital for the continued advancement of allosteric theory, and to generate a multitude of examples in the literature of dynamic allostery. First is the establishment of more sophisticated descriptions of allosteric behavior. Namely, the structural based Ensemble Allosteric Model (EAM) and the energetic based allosteric linkage, which allow for a quantitative description of both the nature and magnitude of allosteric effects even in the absence of a structural change. The second major driving force 
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 Dynamic Allostery An unusual observation on the binding of cyclic AMP (cAMP) by the catabolite activator protein (CAP)37 provided the first experimental evidence that an allosteric signal can be propagated through a protein in the absence of structural changes, as it was theoretically predicted almost three decades earlier by Cooper and Dryden36. CAP is a homodimeric transcription regulator protein, and each subunit consists of both a cAMP-binding domain and a DNA-binding domain. Two cAMP molecules bind the CAP dimer with negative cooperativity and function as allosteric effectors by increasing CAP’s affinity for its DNA substrate. The strong negative cooperativity has been taken advantage of by researchers to figuratively “freeze” binding conformations at intermediate stages. The conformation of the unbound state is referred to as the inactive state, and the conformation with 2 cAMP molecules bound is referred to as the active state. Using chemical shift and relaxation NMR analyses it was exposed that although the binding of the first cAMP molecule to CAP has a minimal effect on the fast dynamics of CAP, the binding of the second cAMP molecule substantially reduces the fast dynamics thereby incurring a large conformational entropy penalty. Isothermal calorimetry (ITC) studies established that the negative cooperativity was purely entropy driven indicating that allosteric interactions may be mediated by changes in dynamics.37,53 Surprisingly, a CAP mutant, CAP-S62F, failed to form the active conformation upon the binding of cAMP. NMR and ITC analyses of the mutant showed that despite the fact that CAP-S62F-cAMP(2) is stuck in the inactive conformation, it binds to DNA 
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 as strongly as wild-type CAP-cAMP(2) with its binding driven by a large conformational entropy originating in enhanced protein motions induced by DNA binding. These results provide strong evidence that changes in protein motions may activate allosteric proteins that appear to be structurally inactive.25 Thrombin is the central protease of the blood coagulation cascade. Tight regulation of its activity is essential to ensure quick blood clotting while preventing uncontrolled thrombosis. The binding of numerous ligands to thrombin at exosite I and the coordination of Na+ have been associated with changes in thrombin conformation and activity, known as thrombin allostery. For over 30 years thrombin allostery has been described using a two state model where it can adopt an anticoagulant (slow) conformation and, after Na+ binding, a structurally distinct procoagulant (fast) state.54 In a recent study, the residues responsible for the transverse relaxation-optimized spectroscopy (TROSY) NMR cross peaks for seven distinct ligation states of thrombin were assigned. Mapping the assignments back to crystal structures have made it possible to distinguish between local and long-range conformational effects.55 These results indicated that the active site, exocite I and the Na+ binding sites all remain in a disordered, dynamic state. A more updated model of thrombin allostery, relying on the plasticity of the enzyme, has been proposed where the low activity of the ‘slow’ form is due to the rapid sampling of multiple states. It is likely that most thrombin substrates will engage exosite I first, where binding is directed by electrostatics56, and therefore do not require a rigid conformation. Subsequent hydrophobic interactions occur via an induced-fit 
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 mechanism that stabilizes exosite I. The occupancy of exosite I improves the affinity of thrombin for Na+ by helping to form the coordination site. Na+ is in rapid equilibrium, so as soon as exosite I is engaged it will bind stably to fully form the active site.57   Recently developed NMR relaxation dispersion experiments have enabled the detection and characterization of weakly populated states.47,49 Interconversion 
between the ground and excited states occurs on the μs–ms timescale, allowing information about the kinetics and thermodynamics of the chemical exchange process as well as the chemical shifts of the excited state to be determined by NMR. In an interesting application of this method, it was shown that binding of the mixed lineage leukemia (MLL) transcription factor to the KIX domain of CREB binding protein promotes the formation of a weakly populated, about 7%, conformation in which the remote c-Myb binding site adopts the c-Myb-bound conformation.58 Consequently, the binding of the first ligand (MLL) alters the structure of the distant second site so that the binding competent conformation seen in the structure of the ternary complex performs in the MLL-CREB binary complex.58 NMR data also reveal an evolutionarily conserved network of hydrophobic amino acids that constitute the pathway through which the allosteric signal is dynamically propagated. Calmodulin (CaM), a key player in calcium mediated cell signaling, has been used as a model system to investigate the role of changes in fast (subnanosecond) internal dynamics and its associated conformational entropy in protein–ligand 
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 binding.59 CaM serves as a messenger protein and transduces calcium signals by binding calcium ions and then modifying its interactions with various target proteins. Backbone and side chain order parameters were measured by NMR for CaM in complex with a series of different peptides from physiological targets of calmodulin. It was found that the apparent change in conformational entropy was linearly related to the change in the overall binding entropy.59 Their observations provide strong evidence that modifier binding induced changes in protein conformational entropy can contribute significantly to the energetics of protein ligand association, in contrast to the commonly held belief that they are necessarily energetically dominated by enthalpic interactions.  
Extension of NMR to Study Allostery in Large Systems  The traditional triple resonance (13C, 15N, 1H) multi-dimensional NMR experiments that are standard for making resonance assignments in proteins are not very effective for proteins with a molecular weight greater than 50 kDa due to increased linewidths associated with the slower tumbling of large molecules, and the spectral overlap from the large number of unique signals. Recent advances in isotope labeling and the development of pulse sequences that take advantage of them have extended the applicability of NMR spectroscopy to protein systems of molecular weights up to 1 MDa.60 The most common approach involves selective 
13CH3 methyl labeling otherwise completely deuterated proteins and employing experiments that make use of a methyl-TROSY effect. Methyl groups are abundant 
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 throughout protein structure, and especially in the hydrophobic core, making them great probes of both structure and dynamics of proteins. In addition, the complex 
13CH3 spin system can be taken advantage of by developing pulse sequences that transfer the magnetism in way that minimizes relaxation loss and gives rise to spectra with high sensitivity.61  Methyl-TROSY NMR enabled the characterization of the 306-kDa aspartate transcarbamoylase (ATCase) enzyme62, a prototypic system for understanding allostery and cooperative binding processes. ATCase catalyzes the first step in the biosynthesis of pyrimidines in which the substrates carbamoylphosphate and aspartate are converted to carbamoylaspartate and inorganic phosphate. The researchers used methyl-TROSY NMR to analyze the binding of substrates, and their effect on the R–T equilibrium in the context of a two-state model. Although only the T state of the enzyme can be observed in spectra, the binding of substrates at the active site shift the equilibrium so that correlations from the R state become visible, allowing the equilibrium constant between ligand-saturated R and T forms of the enzyme to be measured. The equilibrium constant between unliganded R and T forms is also obtained indirectly from relations that emerge due to the fact that ligand binding and the R–T equilibrium are linked. Titrations established that MgATP binding directly perturbs the R–T equilibrium, consistent with the MWC model.62 Prominent studies of the 300-kDa ClpP protease63 and the 20S core-particle proteasome64, also completed by Lewis Kay’s lab, revealed important links 
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 between dynamics and function by quantifying conformational exchange processes that regulate catalytic activity. Methyl-TROSY NMR combined with paramagnetic relaxation enhancement (PRE) studies of the SecA translocase ATPase revealed dynamic allosteric cross talk between the nucleotide binding cleft and the pre-protein binding domain (PBD)65. In addition, the PBD was found to interconvert between an open and a closed conformation, with the conformational equilibrium potentially serving as a simple translocation mechanism. 
 
Part 3: Phosphofructokinase and the Present Study    Phosphofructokinase-1 (PFK-1 or PFK) catalyzes the transfer of a phosphoryl group from MgATP to fructose-6-phosphate (Fru-6-P) producing MgADP and fructose-1, 6-bisphosphate. This reaction represents one of the most characterized enzymes in one of the best studied, most highly conserved metabolic pathways known. PFK catalyzes the phosphorylation reaction by inducing nucleophilic attack by the C1-hydroxyl of Fru-6-P on the γ-phosphorus of MgATP.66 Mg2+ plays a critical role chelating the β- and γ-phosphoryl oxygen molecules, and in most PFK isoforms Mg2+ is essential for enzyme activity.67-69 In PFK from prokaryotes, Saccharomyces cerevisiae, and rabbit muscle sources the reaction is catalyzed in a random sequential mechanism.70,71 The reaction represents the essential and first committed step of the glycolytic pathway, as the only metabolic 
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 fates of fructose-1,6-bisphosphate are dephosphorylation to Fru-6-P or oxidation to pyruvate. Consequently, the PFK catalyzed reaction is under very tight control and the enzyme is allosterically regulated by a variety of effectors that differ between variants of the enzyme from different sources. The glycolytic pathway is conserved among most organisms. PFK is likewise conserved, showing homology in many diverse organisms. There are differences between prokaryotic and eukaryotic PFKs in quaternary structure, size, and regulation. However, the mechanism, sequence, and fundamental mechanisms of regulation been highly conserved throughout evolution. Comparing prokaryotic and eukaryotic PFK, B. stearothermophilus PFK has 44% sequence identity to the N-terminal domain of rabbit muscle PFK and 35% identity to the C-terminal domain.72,73 This has led to the hypothesis that mammalian PFK has undergone gene duplication at some point in evolutionary history.74 Between eukaryotic PFK isoforms, rabbit muscle and human muscle are 95% identical. Among prokaryotic PFK variants, E. coli and B. stearothermophilus have 54% identity, while B. 
stearothermophilus and T. thermophilus are 58% identical.73,75 The high degree of sequence similarity and evolutionary conservation hints at the essential role PFK plays in the central metabolic pathways of organisms. In addition to the ATP-dependent PFK discussed above, plants also have a second type of phosphofructokinase present that uses pyrophosphate (PPi) instead of ATP as the phosphoryl donor called pyrophosphate-fructose-6-phosphate-
31 
 
 phosphotransferase (PFP). PFP reacts near equilibrium and can catalyzes a net flux in the direction of either glycolysis or gluconeogenesis in vivo.76   While the metabolites that are responsible for regulation vary between organisms, most PFK isoforms are under allosteric regulation of some type and to some extent. In the context of linked function thermodynamics, the structural or energetic basis for communication between active and allosteric sites for many of these PFK isoforms is an active focus of investigation. PFK from mammalian tissues was originally the most studied, and has a subunit molecular weight from 75 to 95 kDa.77-79 It forms a tetramer that self-associates into larger oligomers.80,81 Eukaryotic PFK is subject to complex allosteric regulation.74,82 It is inhibited by MgATP, citrate, and [H+], whereas it is activated by MgADP, AMP, fructose-2, 6-bisphosphate (Fru-2,6-BP), fructose-1,6-bisphosphate, cAMP and Pi. The quaternary structure of the enzyme is highly dependent on the presence of allosteric ligands, adding another level of complexity. Specifically, rabbit muscle and rat liver PFK undergo vast self-association that leads to a lowered 𝑘𝑘𝑚𝑚 for Fru-6-P under conditions of substrate and/or activator binding or high protein concentration.83 Bacterial PFKs form a tetramer with a molecular weight of 34 kDa for each subunit. Prokaryotic PFK is still highly allosterically regulated; however there are fewer effector molecules than seen in eukaryotic variants. The less complex allosteric regulation of the prokaryotic enzyme makes it a good model for studying 
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 the allosteric response in PFK. Most prokaryotic PFK isoforms are inhibited by PEP and are activated by MgADP. Although not the focus of this work, there is a second form of prokaryotic PFK, phosphofructokinase-2 (PFK-2). PFK-2 is the minor isozyme and is not homologous to PFK-1. Unlike PFK-1, PFK-2 does not show cooperative interactions 
with fructose-6-P, inhibition by phosphoenol-pyruvate, or activation by ADP.84 The kinetic mechanism of PFK-2 is a ordered sequential bi-bi reaction mechanism where F6P binds first and Fructose-1,6-bisphosphate is the last product released.85 In the case of PFK-2 MgATP appears to act not only as a K-type inhibitor, antagonizing the binding of fructose-6-P as in PFK-1, but also as a V-type inhibitor, decreasing the value of kcat.86 Differences and similarities in the patterns of fructose-6-P binding and the mechanism of inhibition for PFK-1 and PFK-2 provide an example of evolutionary convergence.   
Allostery in Prokaryotic Phosphofructokinase  MgADP activates prokaryotic PFK by increasing its affinity for Fru-6-P binding, which is a response to the low energy in the cell. Phosphoenol-pyruvate, PEP, is a downstream product of glycolysis and inhibits prokaryotic PFK by decreasing the affinity of enzyme for Fru-6-P binding. Thus, prokaryotic PFK is subject to “K-type” regulation. The other substrate is MgATP. MgATP and Fru-6-P antagonize one another's binding markedly, and MgATP brings about positive cooperativity in the Fru-6-P binding profile.87 However, compared to eukaryotic 
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 PFK, the allosteric interaction between MgATP and the effectors is relatively small. MgADP and PEP bind to identical allosteric sites at the allosteric interface of prokaryotic PFK. Exactly how these two different effector molecules regulate PFK from the same site with different effects is still an active area of research. More specifically, the mechanism by which the allosteric signal is transmitted between active sites and allosteric sites is a key unanswered question.  EcPFK and BsPFK are the most studied prokaryotic PFK isoforms and have many similar characteristics. For instance, they show 73% similarity and 54% identity in amino acid sequence. The crystal structures of both enzymes have been 
solved and the α-carbon traces are nearly superimposable.88-90 The crystal structures of EcPFK and BsPFK also indicate almost identical active site binding residues.90-92 Both structures represent a tetrameric enzyme consisting of four identical subunits arranged as a dimer of dimers. Each 34 kDa subunit is composed 
of a large domain and a small domain, and each domain contains a central β-sheet 
sandwiched between several α-helices. Within a tetramer, each subunit makes significant protein-protein contacts with two other subunits, and minimal contact with the remaining subunit.89-91,93 Both the Fru-6-P binding and the allosteric effector binding sites are located at the two different dimer-dimer interfaces of the tetramer. Consequently, each subunit contributes two half Fru-6-P sites and two half allosteric sites, resulting in an average of each subunit containing one full active site and one full allosteric site. The Fru-6-P site is at the cleft between the 
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 large domain and the small domain. The MgATP binding site, located close to the Fru-6-P binding site, is located entirely in the large domain of the subunit.    Despite the fact that BsPFK and EcPFK have a lot of similarity in general characteristics and structure, the kinetic and allosteric characteristics are quantitatively different. Without any effectors and in the presence of a saturating concentration of MgATP, EcPFK displays positive cooperativity for Fru-6-P binding with a Hill number of 3.8.87,94 No such cooperativity is observed for Fru-6-P binding to BsPFK.95 However, positive cooperativity between Fru-6-P binding sites is observed at only intermediate PEP concentrations, termed subsaturating heterotropic cooperativity.35,96 The magnitude of inhibition by effector PEP is greater for BsPFK than EcPFK. The other effector, MgADP, is a strong allosteric activator of EcPFK, but has a small activation effect on BsPFK at 25 °C and below 16 °C inhibition is observed in BsPFK.97 The allosteric properties of BsPFK are also dependent on pH, unlike those of EcPFK.98 The disproportionation equilibria that define allosteric regulation in BsPFK and EcPFK have been extensively examined. The amino acids involved in the binding of the substrate and the allosteric effectors have been extensively substituted and additional specific amino acids lying between the two binding sites have been substituted in an effort to reveal the pathway by which allosteric inhibition and activation are transferred through the enzyme.35,43,87,96-98 Furthermore, the thermodynamic parameters of ligand binding and allosteric coupling free energy have been determined as a function of temperature, pH, and 
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 hydrostatic pressure.35,97,99 Each of these various methods is utilized to perturb the disproportionation equilibrium underlying the allosteric response and to study the effects thereon. Despite their close structural, mechanistic and regulatory likeness, another distinction between EcPFK and BsPFK exists in the thermodynamic driving forces that form the basis for their allosteric inhibition. Van't Hoff analyses have demonstrated that the inhibition of EcPFK is driven by enthalpy and inhibition of BsPFK is governed by entropy. In both cases, the overall coupling free energy, ∆𝐺𝐺𝑎𝑎𝑎𝑎, is positive, as expected for inhibition, and only a few kcal/mol in magnitude.97,100,101 This represents a phenomenon referred to as entropy-enthalpy compensation, which arises from a small difference between large, opposing entropic and enthalpic components of the free energy. In the case of EcPFK both entropy and enthalpy are positive and the ∆𝐻𝐻𝑎𝑎𝑎𝑎 term is larger in magnitude than the ∆𝑆𝑆𝑎𝑎𝑎𝑎 term, leading to positive ∆𝐺𝐺𝑎𝑎𝑎𝑎. For BsPFK both entropy and enthalpy are negative and the 
∆𝑆𝑆𝑎𝑎𝑎𝑎 is larger in absolute value than ΔHay, similarly leading to positive overall ∆𝐺𝐺𝑎𝑎𝑎𝑎.  Van't Hoff analyses have also revealed that an allosteric effector can undergo a temperature induced inversion of allosteric effect. Below 16 °C, Fru-6-P binding by BsPFK is inhibited by MgADP rather than activated as it is at higher temperatures.97 Similarly, above 40 °C, MgATP binding by EcPFK is inhibited by PEP, whereas activation is observed at lower temperatures87. Subsequently, additional means of perturbing of the disproportionation equilibrium have similarly been shown to induce inversion of allosteric effects. For example, low pH 
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 is predicted to cause the MgADP dependent activation of Fru-6-P binding to become inhibition and the PEP dependent inhibition of Fru-6-P binding by BsPFK to become activation.42,97 In the cases of both pH and temperature, either the entropic or enthalpic component of the coupling free energy is more sensitive to the perturbation and at some critical value of perturbation the coupling free energy crosses zero, at which point the inversion of allosteric effect is observed.  Phosphofructokinase from Lactobacillus delbrueckii subspecies bulgaricus (LbPFK) is another PFK isoform studied in our laboratory. LbPFK was reported to be non-responsive to MgADP. Inhibition by PEP was observed at pH 6, but not at pH 8.2.102 The amino acid sequence of LbPFK is 47% identical and 66% similar to that of EcPFK, and 56% identical and 74% similar to BsPFK. The crystal structure that has been solved essentially overlays with that of the other prokaryotic PFKs.103 This relatively non-allosteric enzyme can be used as a blank template to study allosteric regulation. In addition, sequence alignment between LbPFK and the prokaryotic PFKs with stronger allosteric couplings may suggest some important residues for allosteric communication. 
Thermus thermophilus PFK (TtPFK) binds both inhibitor, PEP, and activator, MgADP, significantly more tightly than other bacterial PFKs while exhibiting a significantly smaller extent of inhibition or activation. These characteristics reinforce the principle that binding affinity and allosteric coupling can be both independent and uncorrelated to one another. In addition, the tighter bindings and modest allosteric coupling allow for the easy obtainment of ternary complex 
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 compared to other prokaryotic PFKs studied in the lab.104 It was reported in the past that TtPFK undergoes dissociation along the active site interface under conditions of inhibitor binding, manifesting a similar effect on Fru-6-P binding as has been seen in the eukaryotic isoforms.105 In our lab in it has been determined that the coupling free energies are entropy dominated, as observed previously for PFK from Bacillus stearothermophilus but not for PFK from Escherichia coli, supporting the hypothesis that entropy dominated allosteric effects may be a characteristic of enzymes derived from thermophilic organisms.104  
 
The Present Study 
 The current study uses an energetics based allosteric linkage framework to examine the forces that make up the allosteric coupling free energy and determine the poise of the disproportionation equilibrium that describes it. Specifically, the effect of enzyme perturbation on the entropy and enthalpy components of the coupling free energy, as well as the coupling free energy itself, are observed. First, the allosteric parameters are determined as a function of urea concentration for both BsPFK and EcPFK. Particular attention is paid to the effects of sub-dissociating concentrations of urea. The structure of the enzyme was also perturbed by introducing conservative isoleucine to valine mutations, essentially making the structure more flexible by adding small “holes” via the removal of single methyl groups from four different native isoleucines. Both the urea studies and the hole 
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 mutant data support the notion of different underlying mechanisms for inhibition of PFK in BsPFK and EcPFK.  Methyl-TROSY NMR was employed in order to obtain structural information on BsPFK in all four states of ligation relevant to the allosteric coupling. BsPFK was uniformly 15N and 2H labeled and specifically labeled with δ-[13CH3]-isoleucine 
using an isotopically labeled α-keto acid precursor. Methyl-TROSY experiments were conducted in all four ligation states, and the analysis has allowed specific regions of the enzyme involved in the binding of allosteric ligands and the propagation of the allosteric signal to be identified.    
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 CHAPTER II  
CHARACTERIZATION OF THE W179F/F240W MUTANT OF BACILLUS 
STEAROTHERMOPHILUS PHOSPHOFRUCTOKINASE  
Introduction  
Phosphofructokinase (PFK) transfers the γ-phosphate of MgATP to fructose-6-phosphate (Fru-6-P) forming fructose-1,6-bisphosphate in the first committed step of glycolysis. Due to its significance in glucose metabolism, the reaction is subject to strong metabolic regulation. The regulation of eukaryotic PFK is very complex, however insight into the allosteric regulation of eukaryotic PFK can be gained through the study of the much simpler regulation exhibited by prokaryotic PFK. As a consequence, prokaryotic PFK has been thoroughly characterized and often serves as a model allosteric enzyme.88,90,93,101,106,107 PFK from Bacillus 
stearothermophilus (BsPFK) and Escherichia coli (EcPFK) are two extensively studied prokaryotic PFK homologs. Both enzymes are homotetramers in which monomers associate into a dimer of dimers creating two unique pairs of identical subunit-subunit interfaces. One pair, termed the substrate binding interfaces, contain two Fru-6-P binding sites each for a total of four identical Fru-6-P binding sites per homotetramer. Similarly, each effector binding interfaces have two effector binding sites each, creating four identical effector binding sites. 
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 The activities of EcPFK and BsPFK are inhibited by phosphoenol-pyruvate (PEP)98,108 and activated by MgADP109,110 binding at the same effector binding site. PEP and MgADP both function as K-type effectors, meaning they alter the affinity of PFK for Fru-6-P as opposed to changing the enzyme’s maximum velocity. In both EcPFK and BsPFK there is a prominent antagonism between MgATP and Fru-6-P binding.69,87,111,112 In the case of EcPFK, the antagonism appears to be the result of an allosteric interaction between neighboring active sites as well as within single active sites.87,113 The antagonism observed with BsPFK , however, has been hypothesized to be the result of either an alternative pathway mechanism in which rate limiting binding of MgATP results in a kinetically disfavored pathway at high concentrations of MgATP and low concentrations of Fru-6-P or abortive binding of MgATP in the Fru-6-P binding site.69 In either case, the observed antagonism between Fru-6-P and MgATP binding appears to be a non-allosteric phenomenon. BsPFK and EcPFK each have a single tryptophan per monomer. The indole group of the amino acid tryptophan can serve as a naturally occurring fluorophore in a protein. The λmax of tryptophan is quite sensitive to the polarity of its local 
environment, ranging from ∼308 nm (azurin) to ∼355 nm (glucagon) and roughly correlates with the degree of solvent exposure of the indole. More precisely, the wavelength is determined principally by the electrical potential difference across the long axis of the indole ring.114 This means that the relative direction of a charge from the tryptophan ring is crucial: positive charges create a red shift when on the benzene ring end and a blue shift when on the pyrrole ring end, with the size of the 
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 shift being inversely proportional to the distance from the center of the tryptophan ring. The reverse is true for negative charges. Frequently, spectral shifts are also observed as a result of other phenomena that alter the local environment of the residue, such as the binding of ligands or protein-protein interactions.115  In theory, the single tryptophan residues of BsPFK and EcPFK can be used as fluorescence probes to study and compare the biophysical properties of the enzymes. Turnover is not a problem when measuring ligand dissociation constants or the allosteric coupling constant using a tryptophan fluorescence probe, therefore these values are best determined under equilibrium conditions in the absence of turnover. The fluorescence intensity of the native tryptophan residue in EcPFK, at position 311, is in fact responsive to both substrate and effector binding. Unfortunately, the native tryptophan in BsPFK is largely unresponsive to ligand binding.116 The native position, 179, in BsPFK has been shown to be inaccessible to the bulk solvent and quenchers such as acrylamide.116 This was confirmed by X-ray crystallography structures showing that the residue is buried deep within the core of the protein.91,116  In order to overcome the failure of tryptophan as an effective fluorescence probe in its native position, the present study constructs and characterizes a tryptophan-shifted mutant. In this mutant the native tryptophan at position 179 has been substituted to a phenylalanine and the phenylalanine at position 240 has been substituted to a tryptophan. Phenylalanine was chosen, in an attempt to make the substitutions as conservative as possible, due to its bulky structure and non-
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 polar, hydrophobic nature that resemble tryptophan. As pictured in Figure 2-1, X-ray crystallography structures show that the residue is likely to be at least partially exposed to the solvent. In addition, work completed previously in our lab indicates that changes in the dynamics in the region around position 240 in BsPFK may be associated with the propagation of the allosteric signal.117    
 
Figure 2-1: X-ray crystallography structure highlighting the 
location of the native tryptophan residue (red) and the 
phenylalanine (yellow) that was mutated to tryptophan in 
W179F/F240W-BsPFK. 
  The allosteric coupling between PEP binding and Fru-6-P binding assessed by steady-state kinetic assays is similar to the allosteric coupling seen in the wild-type (WT) enzyme thus indicating that the mutation has not significantly affected the structure or function of the enzyme. Additionally, the kinetic data show that the 
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 apparent dissociation constant for Fru-6-P in the absence of PEP, Kia°, for the variant is equivalent to WT-BsPFK and the apparent dissociation constant for PEP binding in the absence of Fru-6-P, Kiyo, is only 2-fold greater than what is observed for wild-type BsPFK. Moreover, the similarity between this BsPFK variant and WT-BsPFK make the variant a good substitute for WT-BsPFK when a fluorescence probe is needed to study the ligand binding properties of the enzyme. Importantly, the variant’s tryptophan at position 240 has a fluorescence intensity that changes more in response to ligand binding than WT-BsPFK and can serve as a fluorescence probe for looking at the allosteric coupling between substrate, Fru-6-P, and effector, PEP. Due to the similarities between WT-BsPFK and the variant structurally and functionally, and the contrasting fluorescence properties, we were able to use the variant  to examine the validity of the rapid equilibrium assumption in BsPFK by comparing the ligand binding and coupling parameters determined kinetically to those determined thermodynamically under equilibrium conditions.  
 
Materials and Methods 
 
Materials 
 All chemical reagents used in buffers for protein purification, enzymatic assays, and fluorescence assays were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO), Fisher Scientific (Fair Lawn, NJ), or Research 
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 Products International (Mt. Prospect, IL). Deionized distilled water was used throughout. Lyophilized creatine kinase, the ammonium sulfate suspension of glycerol-3-phosphate dehydrogenase, and the potassium salt of phosphoenol-pyruvate were purchased from Roche (Indianapolis, IN). The ammonium sulfate suspensions of aldolase, the ammonium sulfate suspension of triosephosphate isomerase, the disodium salt of fructose-6-phosphate, and the disodium salt of phosphocreatine were purchased from Sigma-Aldrich (St. Louis, MO). The coupling enzymes were extensively dialyzed against 50 mM EPPS pH 8.0, 100 mM KCl, 5 mM MgCl2, and 0.1 mM EDTA before use. NADH and DTT were purchased from Research Products International (Mt. Prospect, IL). Mimetic Blue 1 A6XL resin used in protein purification was purchased from Promatic BioSciences (Rockville, MD). The Mono-Q HR anion exchange column used in protein purification was purchased prepacked for FPLC use from Pharmacia (currently GE Healthcare, Uppsala, Sweden). Macro-Prep High-Q anion exchange resin was purchased from Bio-Rad (Hercules, CA). Amicon Ultra centrifugal filter units (spin concentrators) were from Millipore Corporation (Billerica, MA) and poly(ethylene glycol)-3000 was from Sigma-Aldrich (St. Louis, MO). Site-directed mutagenesis was performed using the QuikChange Site-Directed Mutagenesis System from Stratagene (La Jolla, CA). Oligonucleotides were synthesized and purchased from Integrated DNA Technologies, Inc (Coralville, IA). DNA modifying enzymes and dNTPs were purchased from Stratagene (Cedar Creek, TX), New England Biolabs (Ipswich, MA), or Promega (Madison, WI). 
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 Site-Directed Mutagenesis 
 The plasmid pBR322/BsPFK118 contains the gene for BsPFK behind the native Bacillus stearothermophilus promoter and was received as a generous gift from Simon H. Chang (Louisiana State University). Two successive rounds, one for each mutation, of mutagenesis were performed following the protocol outlined in the QuikChange Site-Directed Mutagenesis System from Stratagene. For each mutation, two complementary oligonucleotides were designed to target the sequence surrounding the codon for each of the mutated amino acids; the template oligonucleotides are shown below: F240W-BsPFK: 5’ – CCA GGA AGC GAC CGG CTG GGA GAC GCG TGT GAC G – 3’ W179F-BsPFK: 5’ – CGA CAT CGC CTT ATT TTC GGG GCT GGC CGG – 3’  
Protein Purification of Wild-Type and W179F/F240W BsPFK  Wild-type BsPFK was expressed in E. coli RL257 cells119, which is a strain of 
E. coli lacking both the pfkA and pfkB genes. The purification of BsPFK was performed as described previously, with a few modifications.95 RL257 cells containing the plasmid pBR322/BsPFK were grown at 37 °C for 16 - 18 hours in LB (Lysogeny Broth) tetracycline (tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L, and tetracycline 15 µg/mL). Cells were harvested by centrifugation and frozen at -20 °C for a minimum of 12 hours. The cells were resuspended in 60 mL of purification buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and sonicated using a Fisher 550 Sonic Dismemberator at 0 °C in 15 second pulses at setting six for 8-12 
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 minutes. The crude lysate was centrifuged at 22,500 x g for 30 minutes at 4 °C. The clarified supernatant was incubated in a 70 °C water bath for 15 minutes, cooled on ice for 15 minutes, and centrifuged again at 22,500 x g for 30 minutes at 4 °C. The supernatant was diluted to at least 500 mL and then loaded onto a 100 mL Mimetic Blue 1 A6XL column that was previously equilibrated with purification buffer. The column was washed with purification buffer until the A280 reached a baseline, and the enzyme was eluted with a 0 - 1.5 M NaCl gradient. Fractions containing enzyme activity were pooled and dialyzed into 20 mM Tris-HCl pH 8.5 and loaded onto a Pharmacia/GE Healthcare Mono-Q HR anion exchange column that was pre-equilibrated with the same buffer. The enzyme was eluted with a 0 - 1 M NaCl gradient, and fractions containing pure BsPFK were combined, concentrated with either a spin concentrator or poly(ethylene glycol) 3000, and then dialyzed into EPPS buffer (50 mM EPPS pH 8.0, 10 mM MgCl2, 100 mM KCl, 0.1 mM EDTA). The final enzyme was determined to be pure by SDS-PAGE, and stored at 4 °C. The 
enzyme concentration was determined by measuring the absorbance at 280 nm (ε = 18910 M-1cm-1).120 
 
Steady-State Kinetic Assays  Activity measurements for PFK were carried out using a coupled enzyme system121,122 in a 0.6 mL reaction volume of EPPS buffer containing 50 mM EPPS, 5 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 2 mM DTT, 0.2 mM NADH, 3 mM ATP, 250 
μg aldolase, 50 μg of glycerol-3-phosphate dehydrogenase, and 5 μg of 
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 triosephosphate isomerase at pH 8.0 and 25 °C unless otherwise noted. 40 μg/mL of creatine kinase and 4 mM phosphocreatine were added as an ATP regenerating system to avoid the accumulation of MgADP, which is an activator. Temperature was controlled using a NESLab RTE-111 circulating water bath. Fru-6-P and PEP were added at varied concentrations as indicated. Assays were started by the 
addition of 10 μL of appropriately diluted PFK and the reaction was monitored as the absorbance at 340 nm decreased over time. The rate of the reaction was measured on Beckman Series 600 spectrophotometers using a linear regression calculation to convert change in absorbance at 340 nm to PFK activity. One unit of 
PFK activity is described as the amount of enzyme needed to produce 1 μmol of fructose-1,6-bisphosphate per minute.  
 
Steady-State Fluorescence Assays Fluorescence intensity measurements were performed using an ISS KOALA fluorometer. Enzyme concentration was 0.5 μM and ligand titrations were performed in buffer containing 50 mM EPPS, 100 mM KCl, 5 mM MgCl2, and 0.1 mM EDTA at pH 8.0 and 25°C unless otherwise indicated. Samples were excited using a xenon arc  lamp and an excitation monochromator to select for 295 nm. The fluorescence intensity was detected using the 2-mm 335 nm Schott cut-on filter or an emission monochromator. Neutral density filters in were placed between the excitation monochrometer and the sample to keep the number of counts in the range of 100,000 counts/sec. Titrations were carried out with a 1.5 mL initial 
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 volume in a standard 1 cm x 1 cm cuvette. All measurements were blank subtracted, and corrected for dilution of enzyme concentration.  
  
Data Analysis  Steady-state kinetics and steady-state fluorescence data were fit using the non-linear least-squares fitting analysis option in Kaleidagraph software version 4.5 (Synergy). For the steady-state kinetic assays the initial velocity data were plotted against concentration of Fru-6-P and fit to the Hill equation8: 
𝑣𝑣 = 𝑉𝑉[𝐴𝐴]𝑛𝑛𝐻𝐻
𝐾𝐾𝑎𝑎
𝑛𝑛𝐻𝐻 + [𝐴𝐴]𝑛𝑛𝐻𝐻 (2-1) where, 𝑣𝑣 is the initial velocity, [𝐴𝐴] is the concentration of the substrate Fru-6-P, 𝑉𝑉 is the maximal velocity, and 𝑅𝑅𝐻𝐻  is the Hill coefficient. 𝐾𝐾𝑎𝑎 is the concentration of Fru-6-P at which the enzyme’s activity is half maximal. Assuming rapid equilibrium for Fru-6-P, which was shown to be valid in EcPFK using a steady-state kinetic method, 
𝐾𝐾𝑎𝑎 is equivalent to the dissociation constant for Fru-6-P from the binary enzyme-substrate complex34,101. MgATP, the other substrate, does not achieve rapid equilibrium during catalytic turnover.87 Data collected using steady-state fluorescence assays were plotted as the relative fluorescence intensity as a function of PEP concentration. The data were fit using eq 2-2. 
𝐹𝐹 = (𝐹𝐹 − 𝐹𝐹𝑜𝑜)[𝑌𝑌]𝑛𝑛𝐻𝐻
𝐾𝐾𝑎𝑎
𝑛𝑛𝐻𝐻 + [𝑌𝑌]𝑛𝑛𝐻𝐻 + 𝐹𝐹𝑜𝑜 (2-2) 
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 where, 𝐹𝐹 is the relative intensity, 𝐹𝐹𝑜𝑜 is the relative intensity in the absence of PEP, [𝑌𝑌] is the concentration of PEP, 𝑅𝑅𝐻𝐻  is the Hill coefficient, and 𝐾𝐾𝑎𝑎 is the apparent dissociation constant for PEP. 𝐾𝐾𝑎𝑎 values obtained from the initial velocity experiments, and 𝐾𝐾𝑎𝑎 values obtained from the steady-state fluorescence experiments were plotted against the concentration of opposing ligand and fit to eq 2-3 or 2-4 
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝑌𝑌]� (2-3) 
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝐴𝐴]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝐴𝐴]� (2-4) where 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for Fru-6-P in the absence of PEP, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for PEP in the absence of Fru-6-P, and 𝑄𝑄𝑎𝑎𝑎𝑎 is the coupling coefficient32,33,123. 𝑄𝑄𝑎𝑎𝑎𝑎 describes the effect of the allosteric effector on the binding of the substrate and/or the effect of the substrate on the binding of the allosteric effector, and is defined below: 
𝑄𝑄𝑎𝑎𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ (2-5) where 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant for Fru-6-P in the saturating presence of PEP, and 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant for PEP in the saturating presence of Fru-6-P. Based on its definition, 𝑄𝑄𝑎𝑎𝑎𝑎 represents the equilibrium constant for the following disproportionation equilibrium: 
[EA] + [YE] 𝑄𝑄𝑎𝑎𝑎𝑎��  [YEA] + [E] (2-6) 
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 where E is free enzyme, YE is the PEP bound binary complex, EA is the Fru-6-P bound binary complex, and EAY is the ternary complex were both ligands are bound simultaneously. The coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎 , is related to the coupling free energy (∆𝐺𝐺𝑎𝑎𝑎𝑎) and its entropy (𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎) and enthalpy (∆𝐻𝐻𝑎𝑎𝑎𝑎) components through the following relationship:  
∆𝐺𝐺𝑎𝑎𝑎𝑎 = ∆𝐻𝐻𝑎𝑎𝑎𝑎 − 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 = −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅�𝑄𝑄𝑎𝑎𝑎𝑎� (2-7) 
∆𝐺𝐺𝑎𝑎𝑎𝑎 represents a standard free energy, although the superscript “0” is removed from the designation to avoid confusion with the use of that superscript for other purposes in notation.32 The coupling entropy and enthalpy components were determined by measuring the coupling constant as a function of temperature and the data were fit to eq 2-8: 
log�𝑄𝑄𝑎𝑎𝑎𝑎�= ∆SayR×2.303 - ∆HayR×2.303 �1T�  (2-8) where, T is absolute temperature in Kelvin, and R is the gas constant (R=1.99 cal K-1 mol-1).  
 
Results  To determine whether or not the tryptophan residue in W179F/F240W-BsPFK serves as a functional fluorescence probe, emission spectra of the enzyme were collected from free enzyme and the two binary complexes. Shown in Figure 2-
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 2, all emission spectra were taken at 25 °C, pH 8.0, λex = 295 nm, and with an enzyme concentration of 0.5 µM. The emission spectrum of W179F/F240W-BsPFK   
 
Figure 2-2: A) Emission spectra of WT-BsPFK, solid lines, and 
W179F/F240W-BsPFK, broken lines. B) is WT-BsPFK and C) is 
W179F/F240W-BsPFK in the apo-form and in the presence of 2 
mM PEP, red, or 1 mM Fru-6-P, blue.  
  is red shifted in comparison to WT-BsPFK (from 332 nm to 350 nm). Another major difference between the two spectra is the overall intensity, which is much greater in the WT-BsPFK enzyme. Figure 2-2B and C show the emission spectra of WT and W179F/F240W-BsPFK in the absence and presence of ligands, respectively. As 
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 anticipated, moving the tryptophan to a more solvent exposed location generated an increase in responsiveness of its intrinsic fluorescence to the binding of ligands. A decrease in the fluorescence intensity of 16 – 20% is associated with PEP binding and a decrease of 5 - 6 % is associated with Fru-6-P binding. WT-BsPFK displays no change in fluorescence intensity in response to the binding of Fru-6-P and only a 10% decrease in response to PEP. The changes in fluorescence intensity were further examined by titrating the mutant with ligand. Again, a similar response to ligand binding is observed (Figure 2-3).   
  
Figure 2-3: A) Relative fluorescence intensity as a function of 
[PEP] and B) [Fru-6-P] for W179F/F240W-BsPFK. 
 
 
 To determine whether or not the structure of the enzyme had been significantly altered in response to the mutation, the functional characteristics of W179F/F240W -BsPFK were determined by steady-state kinetic assays and compared to WT-BsPFK. First, the specific activity of W179F/F240W-BsPFK (169 ± 
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 4 U/mg) was determined to be comparable to WT-BsPFK (178 ± 5 U/mg).  Eq 2-1 was used to determine the 𝐾𝐾𝑎𝑎 values for Fru-6-P at varying concentrations of PEP. Eq 2-3 was then used to determine the binding constants, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  and 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , and coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎, for both mutant and WT enzymes. MgATP concentration was held constant at a saturating concentration of 3 mM and the results are presented in Figure 2-4. Fru-6-P binding in the mutant enzyme is equivalent to that displayed by   
 
Figure 2-4: 𝑲𝑲𝒂𝒂 vs. [PEP] for WT and W179F/F240W-BsPFK by 
steady-state kinetic assays. Circles are wild-type BsPFK in the 
presence of 3 mM MgATP. Squares are the mutant BsPFK in the 
presence of 3 mM MgATP. 
  WT-BsPFK. PEP binding is about 2-fold weaker in the mutant enzyme, as indicated by the shift in the curve to the right. PEP’s ability to inhibit the binding of Fru-6-P is 
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 not affected, as indicated by the similar values for the allosteric coupling constant, 




Figure 2-5: 𝑲𝑲𝒂𝒂 vs. [Fru-6-P] for W179F/F240W-BsPFK by steady-




Table 2-1: Thermodynamic parameters for WT and the 
W179F/F240W mutant of BsPFK determined in the presence (K) 
and absence (F) of MgATP. 
 
 𝑲𝑲𝒊𝒊𝒂𝒂𝒐𝒐   (µM) 𝑲𝑲𝒊𝒊𝒂𝒂𝒐𝒐  (µM) 𝑸𝑸𝒂𝒂𝒂𝒂  
WT (K) 39 ± 2  63 ± 2  0.0021 ± 0.0002  
W179F/F240W (K) 36 ± 1        128 ± 6  0.0029 ± 0.0001  
W179F/F240W (F)   1.9 ± 0.3   110 ± 10  0.0022 ± 0.0007   affected by MgATP. 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , however, is more than an order of magnitude smaller in the absence of MgATP. This is consistent with previous studies that illustrate the ability of MgATP to act as an antagonist to Fru-6-P binding in BsPFK.106 𝐾𝐾𝑎𝑎 for Fru-6-P was 
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 determined using steady-state kinetics at varying concentrations of MgATP (Figure 2-6) with W179F/F240W-BsPFK. As the concentration of MgATP was decreased from 3 mM to 2 μM, the value of 𝐾𝐾𝑎𝑎 for Fru-6-P decreased from 36.0 to 6.6 μM.  The curve was extrapolated to get a 𝐾𝐾𝑎𝑎𝑜𝑜 value of 6.5 ± 0.1 µM.  
 
Figure 2-6: 𝑲𝑲𝒂𝒂 for Fru-6-P as a function of [ATP] concentration at 
25 °C and pH 8.0 measured with steady-state kinetics.  
  To further verify that the mutations have not substantially modified the allosteric behavior of W179F/F240W-BsPFK, the coupling constant was then determined as a function of temperature for both wild-type and the mutant (Figure 2-7). Van’t Hoff analysis for the mutant was performed both in the presence of 
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 MgATP by steady-state kinetic assays, and in the absence of MgATP and turnover by steady-state fluorescence assays. Using eq 2-7 van’t Hoff analysis allowed for the   
 
Figure 2-7: Van’t Hoff analysis of wild-type and W179F/F240W-
BsPFK. Circles are WT-BsPFK in the presence of MgATP. Filled 
squares are the mutant BsPFK in the presence of MgATP. Open 
squares are the mutant BsPFK in the absence of MgATP. 
 
 
 determination of the entropy and enthalpy components of the coupling free energy, which are shown below in Table 2-2. The values for 𝛥𝛥𝐻𝐻𝑎𝑎𝑎𝑎 , and 𝑅𝑅𝛥𝛥𝑆𝑆𝑎𝑎𝑎𝑎  are only     
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 Table 2-2: Thermodynamic parameters associated with the 
allosteric interaction between Fru-6-P and PEP for wild-type and 
mutant W179F/F240W-BsPFK at 25 °C in the presence (K) and 
absence (F) of MgATP. 






WT (K) -17.4 ± 1.3 -21.0 ± 1.3 3.65 ± 0.03 
W179F/F240W (K) -22.9 ± 1.6 -26.2 ± 1.6 3.46 ± 0.04 




Figure 2-8: Relative fluorescence intensity as a function of [PEP] 
at a range of enzyme concentrations from 0.25 µM (red) to 6 µM 
(purple).  




 The primary purpose of this study was to construct a variant of BsPFK that would both have a fluorescence intensity that is responsive to ligand binding and maintain all of the ligand binding and allosteric properties of the unresponsive WT-BsPFK. The added ability to study BsPFK using a purely thermodynamic approach, 
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 using the engineered fluorescence probe, is beneficial because there is no need to invoke the rapid-equilibrium assumption in order to justify a thermodynamic interpretation of the data. As demonstrated by the data above, W179F/F240W-BsPFK meets both of these requirements.  It is critical to be able to relate fluorescence characterization of the mutant directly to wildtype. Overall, the kinetic assessment of WT-BsPFK and W179F/F240W-BsPFK shows that the mutation did not significantly alter the activity or allosteric functionality of the enzyme. However, as the above data indicate, there are a few small differences between the two enzymes. Namely, the binding of PEP is 2-fold weaker in the mutant compared to WT-BsPFK, and the allosteric effect of PEP on Fru-6-P binding is very slightly diminished in the mutant (decrease in 𝛥𝛥𝐺𝐺𝑎𝑎𝑎𝑎  of 0.19 kcal/mol). Van’t Hoff analysis shows that the allosteric coupling between PEP and Fru-6-P is entropy driven at 25 °C for the variant. This means that it is the larger absolute value of the negative entropy component, opposed to the enthalpy component, which determines the positive allosteric coupling free energy that defines PEP as an inhibitor. W179F/F240W-BsPFK’s entropy-driven coupling is in direct contrast to what has been reported for EcPFK43,101, but is agreement with what has been previously reported for WT-BsPFK42. Overall, the kinetic comparison indicates that data obtained using the mutant BsPFK can be extrapolated to wild-type BsPFK and that the mutant is a good candidate for further studies probing a deeper understanding of the biophysical properties involved in BsPFK allosterism. 
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 Using F179W/W240F-BsPFK, the extent of allosteric coupling between fru-6-P and PEP was determined to be the same regardless of whether determined by steady-state kinetic or steady-state fluorescence techniques. The fluorescence assays are performed in the absence of the second substrate, MgATP, demonstrating that MgATP does not have an effect on the allosteric coupling between Fru-6-P and PEP. The apparent dissociation constant for PEP, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , is unchanged by the presence of MgATP. On the other hand, there is a 19-fold increase in 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  in the presence of MgATP. This result was expected, as it has been shown previously that MgATP antagonizes Fru-6-P binding at the active sites.69 In addition, these results are in agreement to those determined previously with another BsPFK tryptophan-shifted mutant112, and with EcPFK101. The steady-state kinetic data presented in Figure 2-6 demonstrate the decrease in 𝐾𝐾𝑎𝑎 as a function of MgATP concentration, and were extrapolated to obtain a value for 𝐾𝐾𝑎𝑎𝑜𝑜 in the absence of MgATP of 6.5 ± 0.1 µM. The validity of the rapid equilibrium assumption depends on the agreement of this value to the 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 value obtained by the fit of the data in Figure 2-4 to eq 2-2, which is 1.9 µM. Even though these values are in very close agreement, they are not within error of each other. One explanation for this discrepancy could be possible failure of the rapid equilibrium assumption at low ATP concentrations due to tight binding. It was also demonstrated that PEP likely causes a dissociation of the tetramer at low enzyme concentrations in W179F/F240W-BsPFK. It is probable that this effect only occurs in the absence and at very low concentrations of Fru-6-P, as Fru-6-P is able to stabilize the active site 
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 interface. This effect could lead to an illusion of tighter binding at these low concentrations, providing an additional potential explanation for the discrepancy in 
𝐾𝐾𝑖𝑖𝑎𝑎
𝑜𝑜 .   
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 CHAPTER III  
THE EFFECT OF UREA ON THE ALLOSTERIC PARAMETERS OF 
PHOSPHOFRUCTOKINASE FROM BACILLUS STEAROTHERMOPHILS AND 
ESCHERICHIA COLI  
Introduction  There is some controversy over the mechanism by which urea denatures proteins, however it is generally described as either indirect, direct or a combination of the two.124 Indirect denaturation refers to a mechanism where urea denatures proteins by disrupting the water structure, which in turn weakens the hydrophobic interaction and makes the protein’s hydrophobic residues less compact and more readily solvated. Through a direct mechanism urea unfolds through direct interactions with proteins, either through stronger electrostatic interactions with the backbone and/or polar residues or through favored van der Waals attractions with protein residues. Most recent studies are in support of a more direct mechanism, although a few indicate that the indirect mechanism probably also plays a role in urea induced protein denaturation.  Even less well understood than the mechanism of urea denaturation is how the structural and energetic properties of proteins change in response to urea. X-ray crystallography structures have shown that protein crystals soaked in low concentrations of urea, and other denaturants, display a reduced average isotropic 
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 MSD (mean square deviations).125,126 This suggests a reduction in the flexibility of the protein in response to the addition of subdenaturing concentrations. Previous studies indicate that polyfunctional interaction between proteins groups and denaturants are responsible for such stabilization.127,128 The interaction of the denaturant molecule with different groups of protein through noncovalent bonding can established nonspecific network of intramolecular interaction. Such denaturant mediated crosslinking of different parts of the protein leads to a decrease of intramolecular dynamics. Although data exists supporting a protein stabilization role for low concentrations of urea, there is a lack of direct biochemical evidence for increased rigidity in the presence of low concentrations of denaturants.  Prokaryotic phosphofructokinase (PFK) catalyzes the phosphorylation of fructose-6-phosphate (Fru-6-P) by MgATP to form fructose 1,6-bisphosphate and MgADP in the first committed step of glycolysis. This crucial glycolytic reaction is allosterically inhibited by the downstream pathway intermediate, phosphoenol-pyruvate (PEP), and activated by product MgADP in a classic example of K-type allosteric regulation. Even though these two small molecules have an opposite effect on the enzyme’s affinity for substrate, Fru-6-P, they bind at the same allosteric site.101,109 In the case of allosteric inhibition of PFK, there is an increase in the 𝐾𝐾𝑎𝑎 for Fru-6-P while PEP is bound at the allosteric site. This change is accompanied by a diminution in the magnitude of the absolute values for the free energy of substrate binding. Accordingly, an allosteric coupling free energy can be defined which relates the difference between the substrate binding energy when 
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 effector is saturating to the binding energy in the absence of effector, or the equivalent reciprocal effect.9-11  
𝑄𝑄𝑎𝑎𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞   = [𝑃𝑃𝐸𝐸𝑃𝑃:𝑃𝑃𝐹𝐹𝐾𝐾: Fru⎼6⎼P][𝑃𝑃𝐹𝐹𝐾𝐾][𝑃𝑃𝐹𝐹𝐾𝐾: Fru⎼6⎼P][𝑃𝑃𝐸𝐸𝑃𝑃:𝑃𝑃𝐹𝐹𝐾𝐾] (3-1) 
𝐾𝐾𝑖𝑖𝑎𝑎
𝑜𝑜  represents the thermodynamic dissociation constant for substrate in the absence of allosteric effector, 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant with allosteric effector saturating the enzyme and 𝑄𝑄𝑎𝑎𝑎𝑎 is the ratio of these two parameters. From the above equations, it is evident that 𝑄𝑄𝑎𝑎𝑎𝑎 also represents the equilibrium constant for the shown disproportionation equilibrium. 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  represents the thermodynamic dissociation constant for substrate in the absence of allosteric effector, 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant with allosteric effector saturating the enzyme and 𝑄𝑄𝑎𝑎𝑎𝑎 is the ratio of these two parameters. From the above equations, it is evident that 𝑄𝑄𝑎𝑎𝑎𝑎 also represents the equilibrium constant for the shown disproportionation equilibrium. 
𝑃𝑃𝐹𝐹𝐾𝐾: Fru⎼6⎼P +  𝑃𝑃𝐸𝐸𝑃𝑃:𝑃𝑃𝐹𝐹𝐾𝐾 𝑄𝑄𝑎𝑎𝑎𝑎��  𝑃𝑃𝐸𝐸𝑃𝑃:𝑃𝑃𝐹𝐹𝐾𝐾: Fru⎼6⎼P + 𝑃𝑃𝐹𝐹𝐾𝐾 (3-2) 
𝑄𝑄𝑎𝑎𝑎𝑎 is related to the coupling free energy though the following relationship 
∆𝐺𝐺𝑎𝑎𝑎𝑎 =  −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅(𝑄𝑄𝑎𝑎𝑎𝑎) (3-3) 
∆𝐺𝐺𝑎𝑎𝑎𝑎 represents a standard free energy, although the superscript “0” is dropped from the designation to avoid confusion with the use of that superscript for other purposes in notation.32 Since ∆𝐺𝐺𝑎𝑎𝑎𝑎describes quantitatively both the nature and the magnitude of the allosteric effect, understanding the basis for that effect requires 
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 one to understand why the disproportionation equilibrium is poised to achieve the value that is does.33  The allosteric coupling free energy between ligands Fru-6-P and PEP for  PFK from both Bacillus stearothermophilus (BsPFK) and Escherichia coli (EcPFK) results from compensating enthalpy and entropy components.97,101 However, there is a very important difference between the two enzymes when it comes to the balance of these thermodynamic forces. In BsPFK, the positive coupling free energy that defines PEP as an inhibitor is opposite in sign of the negative enthalpy term and is therefore determined by the larger absolute value of the negative entropy term.42 This is indicated by the positive slope in the van’t Hoff plot in Figure 3-1.   
 







 However, in EcPFK the positive coupling free energy that defines inhibition by PEP is established by the positive enthalpy component101 and leads to a negative slope with the same analysis. This striking contrast between BsPFK and EcPFK suggests that fundamentally different mechanisms may be responsible for transmitting the allosteric signal between binding sites.  The inactivation, dissociation, and unfolding of EcPFK by urea has been thoroughly examined both in the absence of ligands and in the presence of substrate, Fru-6-P.129-131 The following mechanism has been proposed to describe effect of urea on EcPFK129: 
𝑁𝑁 ↔ 2𝐷𝐷 ↔ 4𝑀𝑀 ↔ 4𝑈𝑈 Where N, the only active species, is the native tetramer, D is the dimer that forms the effector site interface, M is a partially folded monomer and U is a largely unfolded monomer. According to the above mechanism, the quaternary structure of PFK is disrupted before the tertiary structure. Previous data from our lab clearly demonstrates that stabilizing the quaternary structure via covalent disulfide bonds along the allosteric dimer–dimer interface, which also strengthens the active site subunit interface, has essentially no impact on the maximally inhibited or activated state of EcPFK with respect to allosteric perturbations by PEP and MgADP.131 Less work has been done to characterize the effects of urea on BsPFK. However, studies did show that in the absence of ligands, the transition from tetramer to monomer occurs in an apparently concerted dissociation.132 This result is attributed to comparable relative affinities between the allosteric site interface of the dimer and 
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 active site interface of the tetramer. In addition, it is apparent when comparing urea-dependent deactivation curves of BsPFK and EcPFK that activity declines at lower concentrations of urea for EcPFK than BsPFK.129,132  The disproportionation equilibrium, eq 3-2, that defines the allosteric response has been studied by perturbation in various manners including mutation of the amino acid residues involved in catalysis, binding or allosteric communication, adjustment of the pH, variation of temperature, and pressurization.97-99,113 The dissociation and unfolding effects of urea on BsPFK and EcPFK have been previously studied, however the low concentration effects of urea, those that precede dissociation, have been previously ignored. In this chapter, the effect of low concentrations of urea on both the ligand-binding equilibria and the disproportionation equilibrium are determined and compared between BsPFK and EcPFK.  
 
Materials and Methods 
 
Materials 
 All chemical reagents used in buffers for protein purification, enzymatic assays, and fluorescence assays were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO), Fisher Scientific (Fair Lawn, NJ), or Research Products International (Mt. Prospect, IL). Deionized distilled water was used throughout. Creatine kinase, glycerol-3-phosphate dehydrogenase, and the 
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 potassium salt of phospho(enol)pyruvate were purchased from Roche (Indianapolis, IN). The ammonium sulfate suspensions of aldolase, the ammonium sulfate suspension of triosephosphate isomerase, the disodium salt of fructose-6-phosphate, and the disodium salt of phosphocreatine were purchased from Sigma-Aldrich (St. Louis, MO). The coupling enzymes were extensively dialyzed against 50 mM EPPES, 100 mM KCl, 5 mM MgCl2, and 0.1 mM EDTA at pH 8.0 before use. NADH and DTT were purchased from Research Products International (Mt. Prospect, IL). Mimetic Blue 1 A6XL resin used in protein purification was purchased from Promatic BioSciences (Rockville, Maryland). The Mono-Q HR anion exchange column used in protein purification was purchased prepacked for FPLC use from Pharmacia (Uppsala, Sweden). Amicon Ultra centrifugal filter units (spin concentrators) were from Millipore Corporation (Billerica, Massachusetts) and poly(ethylene glycol)-3000 was from Sigma-Aldrich (St. Louis, MO). Site-directed mutagenesis was performed using the Quikchange Site-Directed Mutagenesis System from Stratagene (La Jolla, CA). Oligonucleotides were synthesized and purchased from Integrated DNA Technologies, Inc (Coralville, IA). DNA modifying enzymes and dNTPs were purchased from Stratagene (Cedar Creek, TX), New England Biolabs (Ipswich, MA), or Promega (Madison, WI).  
Protein Purification of BsPFK  The plasmid pBR322/BsPFK 118 contains the gene for BsPFK behind the native Bacillus stearothermophilus promoter and was received as a generous gift 
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 from Simon H. Chang (Louisiana State University). Wild-type BsPFK was expressed in E. coli RL257 cells119, which is a strain of E.coli lacking both the pfkA and pfkB genes. The purification of BsPFK was performed as described previously, with a few modifications.95 RL257 cells containing the plasmid pBR322/BsPFK were grown at 37 °C for 16 - 18 hours in LB (Lysogeny Broth) tetracycline (tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L, and tetracycline 15 µg/mL). Cells were harvested by centrifugation and frozen at -20 °C for a minimum of 12 hours. The cells were resuspended in 60 mL of purification buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and sonicated using a Fisher 550 Sonic Dismemberator at 0 °C in 15 second pulses at setting 6 for 8 - 12 minutes. The crude lysate was centrifuged at 22,500 × g for 30 minutes at 4 °C. The clarified supernatant was incubated in a 70 °C water bath for 15 minutes, cooled on ice for 15 minutes, and centrifuged again at 22,500 × g for 30 minutes at 4 °C. The supernatant was diluted to at least 500 mL and then loaded onto a 100 mL Mimetic Blue 1 A6XL column that was previously equilibrated with purification buffer. The column was washed with purification buffer until the A280 reached a baseline, and the enzyme was eluted with a 0  - 1.5 M NaCl gradient. Fractions containing enzyme activity were pooled and dialyzed into 20 mM Tris-HCl pH 8.5 and loaded onto a Pharmacia Mono-Q HR anion exchange column that was pre-equilibrated with the same buffer. The enzyme was eluted with a 0 - 1 M NaCl gradient, and fractions containing pure BsPFK were combined, concentrated with either a spin concentrator or poly(ethylene glycol)-3000, and then dialyzed into EPPS buffer (50 mM EPPS pH 8.0, 10 mM MgCl2, 100 mM KCl, 0.1 mM EDTA). 
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 The final enzyme was determined to be pure by SDS-PAGE, and stored at 4 °C. 
Enzyme concentration was determined by measuring absorbance at 280 nm (ε = 18910 M-1cm-1).120  






 Steady-State Kinetic Assays  Activity measurements for PFK were carried out using a coupled enzyme system121,122 in a 0.6 mL reaction volume of EPPS buffer containing 50 mM EPPS, 5 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 2 mM DTT, 0.2 mM NADH, 3 mM ATP, 250 
μg aldolase, 50 μg of glycerol-3-phosphate dehydrogenase, and 5 μg of 
triosephosphate isomerase at pH 8.0 and 25 °C unless otherwise noted. 40 μg/mL of creatine kinase and 4 mM of phosphocreatine were added as an ATP regenerating system to avoid the accumulation of MgADP, which is an activator. Temperature was controlled using a NESLab RTE-111 circulating water bath. Fru-6-P and PEP were added at varied concentrations as indicated. Assays were started 
by the addition of 10 μL of appropriately diluted PFK and the reaction was monitored as the absorbance at 340 nm decreased over time. The rate of the reaction was measured on Beckman Series 600 spectrophotometers using a linear regression calculation to convert change in absorbance at 340 nm to PFK activity. One unit of PFK activity is described as the amount of enzyme needed to produce 1 
μmol of fructose-1,6-bisphosphate per minute. Protein was diluted to a concentration of 5.9 µM and was incubated at 25°C for 24 hours at the specified concentration of urea before the assays were performed.  
Data Analysis  Data were fit using the non-linear least-squares fitting analysis option in Kaleidagraph software version 4.5 (Synergy). For the steady-state kinetic assays 
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 the initial velocity data were plotted against concentration of Fru-6-P and fit to the Hill equation8: 
𝑣𝑣 = 𝑉𝑉[𝐴𝐴]𝑛𝑛𝐻𝐻
𝐾𝐾𝑎𝑎
𝑛𝑛𝐻𝐻 + [𝐴𝐴]𝑛𝑛𝐻𝐻  (3-4) where, 𝑣𝑣 is the initial velocity, [𝐴𝐴] is the concentration of the substrate Fru-6-P, 𝑉𝑉 is the maximal velocity, and 𝑅𝑅𝐻𝐻  is the Hill coefficient. 𝐾𝐾𝑎𝑎 is defined as the concentration of Fru-6-P at which the enzymes activity is half maximal. Assuming rapid equilibrium, 𝐾𝐾𝑎𝑎 is equivalent to the dissociation constant for Fru-6-P from the binary enzyme-substrate complex. 𝐾𝐾𝑎𝑎 values obtained from the initial velocity experiments were plotted against the concentration of opposing ligand and fit to eq 3-5.  
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝑌𝑌]� (3-5) where 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for Fru-6-P in the absence of PEP, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for PEP in the absence of Fru-6-P, and 𝑄𝑄𝑎𝑎𝑎𝑎 is the coupling coefficient32,33,123. 𝑄𝑄𝑎𝑎𝑎𝑎 describes the effect of the allosteric effector on the binding of the substrate and/or the effect of the substrate on the binding of the allosteric effector. Based on its definition, 𝑄𝑄𝑎𝑎𝑎𝑎 represents the equilibrium constant for the disproportionation equilibrium (eq 3-2). The coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎 , is related to the coupling free energy (∆𝐺𝐺𝑎𝑎𝑎𝑎) and its entropy (𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎) and enthalpy (∆𝐻𝐻𝑎𝑎𝑎𝑎) components through the following relationship, which is an elaboration of eq 3-3:  
∆𝐺𝐺𝑎𝑎𝑎𝑎 = ∆𝐻𝐻𝑎𝑎𝑎𝑎 − 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 = −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅�𝑄𝑄𝑎𝑎𝑎𝑎� (3-6) 
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 The coupling entropy and enthalpy components were determined by measuring the coupling constant as a function of temperature and the data were fit to eq 3-7: 
ln(Qay) = ∆Say2.3×R − ∆Hay2.3×R �1T�     (3-7) where, T is absolute temperature in Kelvin, and R is the gas constant (R=1.99 cal K-1 mol-1).  
 
Results    First, the effect of urea on the specific activity of both BsPFK and EcPFK was established. Enzyme samples were stored at a concentration of 59 µM and 4 °C after purification. Prior to preforming any steady-state kinetic assays, the enzyme stocks were diluted 10-fold and incubated at 25 °C at the indicated concentration of urea for 24 hours. It was determined that after 24 hours no further changes in the enzyme activity were occurring, and we concluded that the system was at equilibrium. The enzyme remained in the presence of urea until right before preforming the assay, when it was diluted into buffer to a concentration appropriate for running the assay. The enzyme activity did not change over the course of the assays, which were always run within 5 minutes of dilution. The reactivation of EcPFK has been thoroughly characterized and clearly shows that no enzymatic activity is regained during the course of the assays.129 At urea concentrations ranging from 0 to 5 M, it is apparent from Figure 3-2A, urea is 
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 causing a dramatic loss of activity at high concentrations. Loss of activity indicates that the enzyme is no longer in the tetrameric form, which is the simplest active form of the enzyme. This effect, however, occurs at lower concentrations of urea for EcPFK than BsPFK. In the case of BsPFK, we begin to see a 50% reduction in the enzyme’s specific activity at 4.5 M urea. EcPFK reaches this point at 2.2 M urea. At lower concentrations, 0 - 0.5 M urea, another difference is observed between the two enzymes. BsPFK steadily gains specific activity from 0 to 0.2 M urea and then maintains the higher level of activity at the low concentration range as shown in Figure 3-2B. This effect on PFK activity is not observed in EcPFK.  
 
Figure 3-2: Relative specific activity of EcPFK (squares) and 
BsPFK (circles) as a function of urea concentrations ranging 
from A) 0 - 5 M and B) 0 - 0.5 M.   
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 To establish the magnitude of PEP inhibition in BsPFK and EcPFK at various concentrations of urea, the apparent dissociation constants for Fru-6-P were determined as a function of PEP concentration at 0, 0.5 and 2 M urea. Urea concentrations of 0, 0.5, and 2 M all represent low concentrations of urea that precede dissociation of the tetramer in BsPFK. In EcPFK the specific activity in 2 M urea is at 70 % of the value obtained at 0 M urea, however all of the activity measured is produced by enzyme portion remaining in the tetrameric form. The dissociation constants for Fru-6-P were obtained from individual titration curves and fit to eq 3-4 at various PEP concentrations. The data for the apparent dissociation constants as a function of PEP concentration, fit to eq 3-5 to obtain the allosteric coupling parameter (𝑄𝑄𝑎𝑎𝑎𝑎), are shown in Figure 3-3A and B for BsPFK and EcPFK, respectively. In addition, the dissociation constants for Fru-6-P in the   
 
Figure 3-3: The log of the apparent 𝑲𝑲𝒂𝒂 for Fru-6-P as a function 
of the log of [PEP] for A) BsPFK and B) EcPFK. Data in absence of 
urea are shown with open circles, data in the presence of 0.5 M 
urea with closed circles and 2 M urea with open squares. 
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 absence of PEP (𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 ) and for PEP in the absence of Fru-6-P (𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 ) are obtained from these fits. 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  was not changed by the addition of urea in either BsPFK or EcPFK. There was a 2-fold increase in 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  at 0.5 and 2 M urea compared to 0 M urea in the case of BsPFK, but no change was seen for EcPFK. The magnitude of inhibition in BsPFK was enhanced 2.3-fold in 0.5 M urea, and 3.2 fold in 2 M urea, compared to native conditions. Conversely, no effect was seen on the allosteric coupling in EcPFK at 0.5 or 2 M urea compared to 0 M. The data for the allosteric coupling parameters were used to calculate the standard allosteric coupling free energies, 
∆𝐺𝐺𝑎𝑎𝑎𝑎. The resulting values of 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , 𝑄𝑄𝑎𝑎𝑎𝑎, and ∆𝐺𝐺𝑎𝑎𝑎𝑎 are presented in Table 3-1 for both BsPFK and EcPFK along with the same values obtained at 0.5 and 2 M urea.  
Table 3-1: Ligand dissociation constants and coupling constants 
for B. stearothermophilus and E. coli PFK at various 
concentrations of urea and 25 °C. 
  [Urea]  
(M) 
𝑲𝑲𝒊𝒊𝒂𝒂





𝑸𝑸𝒂𝒂𝒂𝒂 ∆𝜟𝜟𝒂𝒂𝒂𝒂  
(kcal/mol) 
BsPFK 0 0.022 ± 0.001 0.038 ± 0.001 0.0016 ± 0.0001 3.8 ± 0.1 
- 0.5 0.024 ± 0.001 0.077 ± 0.002 0.0007 ± 0.0001 4.3 ± 0.1 
- 2 0.022 ± 0.001 0.081 ± 0.003 0.0005 ± 0.0001 4.5 ± 0.2 
EcPFK 0 0.346 ± 0.009 0.28 ± 0.02 0.015 ± 0.001 2.5 ± 0.1 
- 0.5 0.338 ± 0.013 0.27 ± 0.03 0.018 ± 0.001 2.4 ± 0.1 
- 2 0.323 ± 0.007 0.24 ± 0.01 0.015 ± 0.001 2.5 ± 0.1 
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 To further characterize the effect of urea on the allosteric coupling in BsPFK, the allosteric coupling was measured at additional concentrations of urea and the data is shown in Figure 3-4. The numerical values corresponding to the coupling   
 
Figure 3-4: The allosteric coupling free energy, ∆𝜟𝜟𝒂𝒂𝒂𝒂 , for BsPFK 
at a range of urea concentrations from 0 - 4 M. 
  free energy at the range of urea concentrations from 0 - 4 M are shown in Table 3-2. The allosteric coupling between Fru-6-P and PEP is enhanced as a function of urea concentration from 0 to 0.5 M urea, and the effect is maintained until urea concentrations reach about 2 M. At 4 M urea the extent of coupling is reduced back to levels seen in the absence of urea. 
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 Table 3-2: Numerical values for the allosteric coupling free 
energy at a range of urea concentrations from 0 - 4 M and 25 °C. 
 











Figure 3-5: Variation in the log of 𝑸𝑸𝒂𝒂𝒂𝒂 verses reciprocal 
temperature of BsPFK at various concentrations of urea. Closed 
circles represent the absence of urea, open circles are at 0.25 M 
urea, closed squares are at 1 M urea and open squares are at 4 M 
urea. 
   signifying that there is not a temperature dependent change in heat capacity, ∆𝐶𝐶𝑝𝑝, over this range of temperatures at any of the tested concentrations of urea. The plot reveals that at 0.250 M both the entropy and enthalpy components of the coupling free energy become more negative compared to 0 M urea. There is a larger change in the 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 component, leading to an overall decrease in entropy-enthalpy compensation and increased allosteric coupling. This trend continues when the concentration of urea is further increased to 1 M. From 0 to 4 M urea we see an even further decrease in both the entropy (7.5 ± 1.5 kcal/mol) and enthalpy (7.4 ± 
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 1.6 kcal/mol) terms. However, at this concentration of urea ∆𝐺𝐺𝑎𝑎𝑎𝑎 has returned to the value obtained in the absence of urea and compensation remains the same. The values corresponding to ∆𝐻𝐻𝑎𝑎𝑎𝑎, 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎, and ∆𝐺𝐺𝑎𝑎𝑎𝑎 are listed below in Table 3-3 for 0, 0.250, 1 and 4 M urea. 
 
Table 3-3: Thermodynamic parameters quantifying the 
inhibition of BsPFK by PEP at various concentrations of urea and 
25 °C. 
[Urea]  
(M) ∆𝜟𝜟𝒂𝒂𝒂𝒂  (kcal/mol) 𝑻𝑻∆𝑻𝑻𝒂𝒂𝒂𝒂 (kcal/mol) ∆𝜟𝜟𝒂𝒂𝒂𝒂 (kcal/mol) Rel. SA (%) 
0 -6.0 ± 0.9 -9.7 ± 0.8 3.8 ± 0.1 100 
0.25 -6.4 ± 1.5 -10.4 ± 1.4 3.9 ± 0.1 114 
1 -8.5 ± 1.3 -12.6 ± 1.3 4.2 ± 0.1 112 





 We began to see the dissociation effects of urea, shown as a decrease in the specific activity, at lower concentrations in EcPFK than in BsPFK. In fact, it takes 4.5 M urea, more than twice the concentration of urea that was required to have the same effect on EcPFK, to reduce the specific activity of BsPFK by 50%. These stability differences likely stem from the fact that BsPFK is a thermophilic enzyme, whereas EcPFK is a more flexible mesophilic enzyme. Previous work has shown using a combination of steady-state kinetic assays, which monitor dissociation at the active site interface, and intrinsic fluorescence assays, which monitor the 
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 allosteric site interface, that in EcPFK the decrease in activity with urea corresponds to the dissociation of the tetramer at the active site interface into dimers.129 This is in contrast to what is believed to occur in BsPFK, which appears to undergo the transition from tetramer to monomer in a concerted dissociation with changes in activity and intrinsic fluorescence occurring simultaneously.132 The remainder of this study focused on the previous uncharacterized effects of low concentrations of urea on BsPFK and EcPFK. An increase in specific activity at low urea concentrations was seen uniquely in BsPFK. The effect of urea on the allosteric coupling between Fru-6-P and PEP was also determined. The extent of inhibition by PEP is given by the standard free energy, ∆𝐺𝐺𝑎𝑎𝑎𝑎, for the disproportionation equilibrium (eq 3-1). All four of the species that contribute to the poise of this equilibrium are potentially influenced by urea. The value for ∆𝐺𝐺𝑎𝑎𝑎𝑎 is derived from the difference between the perturbations of the free energy of formation when both ligands simultaneously versus the sum of the perturbations experienced by the binding of each ligand individually. Changes to the enzyme, as the result of urea, must enhance or relieve conflict in the ternary complex in order to alter the value for ∆𝐺𝐺𝑎𝑎𝑎𝑎, thereby altering the degree of inhibition.  In the case of EcPFK, at urea concentrations up to 2 M, there is no effect on the allosteric coupling. This is not true for BsPFK, which has increased allosteric coupling over the same range of low urea concentrations for which it has an increased specific activity. The different effects seen on PEP inhibition in the presence of urea between BsPFK and EcPFK are intriguing. There is one additional 
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 observation made from the data presented in Figure 3-3. For BsPFK in low urea conditions the binding of inhibitor PEP, or 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , is 2-fold weaker. However, from 0 to 1 M urea, the allosteric coupling free energy between Fru-6-P and PEP increased by 0.4 ± 0.1 kcal/mol, signifying that PEP is a significantly more effective inhibitor. The fact that low concentrations of urea produced an increase in coupling while making the PEP binding weaker suggests that the binding of the inhibitor and the actual inhibition are independent of one another as we have observed previously.100,134,135 There is evidence for fundamentally different mechanisms of coupling between binding sites in these two PFK isoforms, as indicated by contrasting thermodynamic driving forces. A possible explanation for the different effects at low urea concentrations is that urea is a producing a stabilizing effect on the tertiary structure of the enzyme, altering the conformational dynamics, when concentrations are low. The allosteric coupling in BsPFK is entropically driven; on the other hand, coupling in EcPFK is enthalpy driven. Conceivably, altering the conformational dynamics would not necessarily have the same effect on both enzymes.  Van’t Hoff analysis on the allosteric coupling in BsPFK reveals that both the entropy and enthalpy components of the coupling free energy increase in absolute value, becoming more negative. At low concentrations of urea, less than 1M, the entropy term decreases to a larger extent than the enthalpy term. This alters the degree of entropy enthalpy compensation leading to the observed increase in allosteric coupling. The dramatic decrease observed in the entropy component of 
84 
 
 the coupling indicates that reduced thermal fluctuations are present in the propagation of the allosteric signal at low concentrations of urea than are under native conditions, supporting the notion that urea stabilizes protein structures at low concentrations of urea. It is evident from the data that the enzyme compensates for the dramatic decrease in coupling entropy with a decrease in the coupling enthalpy. Stabilizing the enzyme with low concentrations of urea changes the entropy and enthalpy terms to such a great degree that the balance between them is also vulnerable to change. These changes alter the poise of the disproportionation equilibrium and consequently the effectiveness of PEP as an inhibitor.    
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 CHAPTER IV  
THE EFFECT OF ADDING SMALL CAVITIES TO THE STRUCTURE OF 
PHOSPHOFRUCTOKINASE FROM BACILLUS STEAROTHERMOPHILUS AND 
ESCHERICHIA COLI ON THE ALLOSTERIC COUPLING FREE ENERGY VIA SINGLE 
ISOLEUCINE TO VALINE MUTATIONS  
Introduction  The enzymes that catalyze the commitment steps of metabolic pathways are subject to intense regulation via allosteric mechanisms. The molecular basis of allosteric regulation is still not well understood in most cases. However, due to the key role these enzymes play, the ability to manipulate allosteric control mechanisms holds promise for drug design.136-141 For this reason, an enhanced view of the molecular mechanisms behind the regulation of allosteric enzymes is a prerequisite for rational drug design. Prokaryotic phosphofructokinase (PFK) has been extensively studied and characterized, resulting in an abundance of kinetic, structural, and thermodynamic knowledge.43,87,88,90,93,98,101,106-110,120 Consequently, prokaryotic PFK in general, and PFK from Bacillus stearothermophilus (BsPFK) and Escherichia coli (EcPFK) specifically, serve as model allosteric enzymes to explore the molecular mechanisms of allosteric regulation as well as the thermodynamic basis of the allosteric coupling. Prokaryotic PFK catalyzes the phosphorylation of fructose-6-
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Figure 4-1: Van’t Hoff plots of BsPFK (circles) and EcPFK 
(squares). 
  energy between ligands Fru-6-P and PEP for both BsPFK and EcPFK results from compensating enthalpy and entropy components under normal conditions at 25 °C.97,101 In EcPFK, the positive coupling free energy that defines inhibition by PEP is established by the larger positive enthalpy component.101 This is indicated by the negative slope in the van’t Hoff plot in Figure 4-1. However, in BsPFK the positive coupling free energy that defines PEP as an inhibitor is opposite in sign of the negative enthalpy term and is therefore determined by the larger absolute value of the negative entropy term42 and leads to a positive slope with the same analysis. This striking contrast between BsPFK and EcPFK suggests that fundamentally 
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 different mechanisms may be responsible for transmitting the allosteric signal between the Fru-6-P and PEP binding sites. Despite evidence for unique PEP inhibition mechanisms, the prokaryotic PFK homologs BsPFK and EcPFK share 73% similarity and 54% identity in amino acid sequence. The X-ray crystallographic structures of these two enzymes with various ligand combinations bound have α-carbon traces that are nearly superimposable.88-90 This is demonstrated by an overlay of BsPFK and EcPFK monomers in Figure 4-2. The crystal structures of EcPFK and BsPFK also indicate   
 
Figure 4-2: Overlay of the apo-BsPFK structure (cyan) and the 
apo-EcPFK structure (red). 
  almost identical active site binding residues.90-92 Both enzymes are a tetrameric structure consisting of four identical subunits arranged as a dimer of dimers with the substrate and effector binding sites located at alternating interfaces.  
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 B. stearothermophilus is a moderate thermophile that grows natively at 55 °C, and BsPFK is correspondingly temperature-stable. The stability of the enzyme reflects the evolutionary requirement for enzyme stability under high environmentally imposed temperatures. Many studies have attempted to uncover the source of increased thermal stability in thermophilic enzymes, but it appears that there is not a single molecular or thermodynamic explanation.142 Instead, increased thermostability appears to rely on a variety of stabilizing effects. In a recent review, Razvi and Scholtz compiled the available data and generated stability curves for 26 sets of homologous proteins from thermophiles and mesophiles to determine the thermodynamic mode of stabilization used in each case.142 Stability curves demonstrate how the conformational stability varies with temperature and it was concluded that the most common way that thermophilic proteins in the study achieve higher stability is by increasing their intrinsic stability at all temperatures.  The comparison of three-dimensional structures of homologous pairs of proteins from mesophiles and thermophiles has shown that the increase in stability can be achieved in various ways. The most general stabilizing feature is an increased number, and optimization, of electrostatic interactions.143 Other common 
features include the stabilization of α-helices, an increase in the number of proline and C-β-branched residues and a decrease in the number of uncharged polar amino acids. Other features that tend to have a more minor influence include an increased number of hydrogens bonds, higher packing densities, improved hydrophobic 
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 interactions, optimized surface areas, decreased volumes, fewer cavities, and a shortening of the polypeptide chain.143 Many of these characteristics also lead to increased rigidity. In the case of BsPFK, Kim et al. showed that the native tryptophan position is quite rigid.116 Additional fluorescence studies using tryptophan-shifted mutants revealed that a majority of the BsPFK structure is rigid.112,120,144 In the present study, four different isoleucine to valine mutations were made to the BsPFK enzyme in an attempt to make the BsPFK structure more flexible, and perhaps, modify the extent of inhibition by PEP. Each modification resulted in the loss of a single methylene group from the native structure, leaving a small cavity at the affected location. In a structural and genetic analysis of protein stability, Matthews compiled systematic mutational analyses of hydrophobic residues in proteins including 9 different Ile  Val mutations.145 The change in denaturation free energy between WT and mutants ranged from 0.5 to 1.8 kcal/mol, with an average ΔΔG of 1.3 ± 0.4 kcal/mol. In another study, the thermodynamic parameters for the denaturation of five Ile  Val lysozyme mutants determined by scanning calorimetry showed decreased stability compared to wild-type lysozyme in all cases.146 Larger and diverse changes in denaturation enthalpy were observed in comparison to the denaturation free energy, which were largely compensated for by changes in the denaturation entropy. X-ray crystallography studies of these lysozyme variants revealed identical overall structures and only small structural rearrangements were observed locally around 
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 some mutation sites. More recently, Roche et al. used 10 cavity containing mutants of staphylococcal nuclease to establish that pressure unfolds proteins primarily as a result of cavities that are present in the folded state and absent in the unfolded one.147 Based on previous studies analyzing the effect of cavities in protein structures, we hypothesized that the addition of such a small cavity to the BsPFK enzyme should not substantially alter the overall structure of the enzyme. On the other hand, the cavity would likely have a modest effect on the stability of all four forms appearing in eq 4-1. This, in return, would possibly alter the allosteric coupling free energy that defines the magnitude of inhibition by shifting the poise of the equilibrium between the four relevant species. As a comparison, we also introduced a similar mutation into EcPFK, which has a more flexible structure. The different thermodynamic composition of allosteric coupling in EcPFK adds extra intrigue. In EcPFK there is a leucine instead of a valine at this position. Therefore, in the case of I154V, we are also removing a methylene group. This shortens the overall length of the R-group and still creates a small cavity in structure of the enzyme, analogous to the isoleucine to valine mutations made in BsPFK.   
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 Materials and Methods 
 
Materials  All chemical reagents used in buffers for protein purification, enzymatic assays, and fluorescence assays were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO), Fisher Scientific (Fair Lawn, NJ), or Research Products International (Mt. Prospect, IL). Deionized distilled water was used throughout. Lyophilized creatine kinase, the ammonium sulfate suspension of glycerol-3-phosphate dehydrogenase, and the potassium salt of phosphoenol-pyruvate were purchased from Roche (Indianapolis, IN). The ammonium sulfate suspensions of aldolase, the ammonium sulfate suspension of triosephosphate isomerase, the disodium salt of fructose-6-phosphate, and the disodium salt of phosphocreatine were purchased from Sigma-Aldrich (St. Louis, MO). The coupling enzymes were extensively dialyzed against 50 mM EPPS pH 8.0, 100 mM KCl, 5 mM MgCl2, and 0.1 mM EDTA before use. NADH and DTT were purchased from Research Products International (Mt. Prospect, IL). Mimetic Blue 1 A6XL resin used in protein purification was purchased from Promatic BioSciences (Rockville, MD). The Mono-Q HR anion exchange column used in protein purification was purchased prepacked for FPLC use from Pharmacia (currently GE Healthcare, Uppsala, Sweden). Macro-Prep High-Q anion exchange resin was purchased from Bio-Rad (Hercules, CA). Amicon Ultra centrifugal filter units (spin concentrators) were from Millipore Corporation (Billerica, MA) and poly(ethylene glycol)-3000 was from 
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 Sigma-Aldrich (St. Louis, MO). Site-directed mutagenesis was performed using the QuikChange Site-Directed Mutagenesis System from Stratagene (La Jolla, CA). Oligonucleotides were synthesized and purchased from Integrated DNA Technologies, Inc (Coralville, IA). DNA modifying enzymes and dNTPs were purchased from Stratagene (Cedar Creek, TX), New England Biolabs (Ipswich, MA), or Promega (Madison, WI).  
Site-Directed Mutagenesis 
 The plasmids p-ALTER1/BsPFK and p-ALTER1/EcPFK contain the gene for BsPFK and EcPFK, respectively. Mutagenesis was performed on these plasmids following the protocol outlined in the QuikChange Site-Directed Mutagenesis System from Stratagene. Two complementary oligonucleotides were designed to target the sequence surrounding the codon for each of the mutated amino acids; the template oligonucleotides are shown below: I150V-BsPFK: 5’– ATA CGG TCA TTG ATG CCG TCG ACA AAA TCC GCG AC –3’ I53V-BsPFK: 5’– GCC ATC GAC AAA GTG CGC GAC ACG G –3’ I234V-BsPFK: 5’– GAC TTC GGC CGG CAA GTG CAG GAA G –3’ L154V-EcPFK: 5’– TGT AGA AGC GAT CGA CCG TGT GCG TGA CAC –3’  
Protein Purification of Wild-Type, I150V, I153V, and I234V-BsPFK  The plasmid p-ALTER1/BsPFK contains either the gene for BsPFK or the mutated genes. Expression from this plasmid occurs via the tac promoter. Wild-
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 type BsPFK was expressed in E. coli RL257 cells119, which is a strain lacking both the pfkA and pfkB genes. The purification of BsPFK was performed as described previously95, with a few modifications. RL257 cells containing the plasmid p-ALTER1/BsPFK were grown at 37 °C for 16 - 18 hours in Lysogeny Broth with tetracycline (tryptone 10 g/L, yeast extract 5 g/L, NaCl 10 g/L, and tetracycline 15 µg/mL). Induction of expression with 2 mM IPTG was carried out at the beginning of the growth. Cells were harvested by centrifugation and frozen at -20 °C for a minimum of 12 hours. The cell pellet was resuspended in 60 mL of purification buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA) and sonicated using a Fisher 550 Sonic Dismemberator at 0 °C in 15-second pulses at setting six for 8 - 12 minutes. The crude lysate was centrifuged at 22,500 × g for 30 minutes at 4 °C. The clarified supernatant was incubated in a 70 °C water bath for 15 minutes, cooled on ice for 15 minutes, and centrifuged again at 22,500 × g for 30 minutes at 4 °C. The supernatant was diluted to at least 500 mL and then loaded onto a 100 mL Mimetic Blue 1 A6XL column that was previously equilibrated with purification buffer. The column was washed with purification buffer until the A280 reached a baseline, and the enzyme eluted with a 0 - 1.5 M NaCl gradient. Fractions containing enzyme activity were pooled and dialyzed into 20 mM Tris-HCl pH 8.5 and loaded to a Pharmacia/GE healthcare Mono-Q HR anion exchange column that was pre-equilibrated with the same buffer. The enzyme was eluted with a 0 - 1 M NaCl gradient, and fractions containing pure BsPFK were combined, concentrated with either a spin concentrator or poly(ethylene glycol)-3000, and then dialyzed into 
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 EPPS buffer (50 mM EPPS pH 8.0, 10 mM MgCl2, 100 mM KCl, and 0.1 mM EDTA). The final enzyme was determined to be pure by SDS-PAGE, and stored at 4 °C. 
Protein concentration was determined by measuring absorbance at 280 nm (ε = 18910 M-1cm-1).120 
 





 Steady-State Kinetic Assays  Activity measurements for PFK were carried out using a coupled enzyme system121,122 in a 0.6 mL reaction volume of EPPS buffer containing 50 mM EPPS pH 8.0, 5 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 2 mM DTT, 0.2 mM NADH, 3 mM ATP, 
250 μg aldolase, 50 μg of glycerol-3-phosphate dehydrogenase, and 5 μg of triosephosphate isomerase at 25 °C unless otherwise noted. Creatine kinase (40 
μg/mL) and phosphocreatine (4 mM) were added as an ATP regenerating system to avoid the accumulation of MgADP, which is an activator. Temperature was controlled using a NESLab RTE-111 circulating water bath. Fru-6-P and PEP were added at varied concentrations as indicated. Assays were started by the addition of 
10 μL of appropriately diluted PFK and the reaction was monitored as the absorbance at 340 nm decreased over time. The rate of the reaction was measured on Beckman Series 600 spectrophotometers using a linear regression calculation to convert change in absorbance at 340 nm to PFK activity. One unit of PFK activity is described as the amount of enzyme needed to produce 1 μmol of fructose-1,6-bisphosphate per minute.  
  
Data Analysis  Data were fit using the non-linear least-squares fitting analysis option in Kaleidagraph software version 4.5 (Synergy). For the steady-state kinetic assays the initial velocity data were plotted against concentration of Fru-6-P and fit to the Hill equation8: 
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 𝑣𝑣 = 𝑉𝑉[𝐴𝐴]𝑛𝑛𝐻𝐻
𝐾𝐾𝑎𝑎
𝑛𝑛𝐻𝐻 + [𝐴𝐴]𝑛𝑛𝐻𝐻 (4-2) where, 𝑣𝑣 is the initial velocity, [𝐴𝐴] is the concentration of the substrate Fru-6-P, 𝑉𝑉 is the maximal velocity, and 𝑅𝑅𝐻𝐻  is the Hill coefficient. 𝐾𝐾𝑎𝑎 is defined as the concentration of Fru-6-P at which the enzymes activity is half-maximal. Assuming rapid equilibrium for Fru-6-P, which was shown to be valid in EcPFK using a steady-state kinetic method, 𝐾𝐾𝑎𝑎 is equivalent to the dissociation constant for Fru-6-P from the binary enzyme-substrate complex.34,101 Values of  𝐾𝐾𝑎𝑎 obtained from the initial velocity experiments were plotted against the concentration of opposing ligand and fit according to 
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝑌𝑌]� (4-3) where 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for Fru-6-P in the absence of PEP, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for PEP in the absence of Fru-6-P, and 𝑄𝑄𝑎𝑎𝑎𝑎 is the coupling coefficient.32,33,123 𝑄𝑄𝑎𝑎𝑎𝑎 describes the effect of the allosteric effector on the binding of the substrate, and is defined as 
𝑄𝑄𝑎𝑎𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞      (4-4) where 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant for Fru-6-P in the saturating presence of PEP, and 𝐾𝐾𝑖𝑖𝑎𝑎∞ is the dissociation constant for PEP in the saturating presence of Fru-6-P. By definition, 𝑄𝑄𝑎𝑎𝑎𝑎 represents the equilibrium constant for the disproportionation equilibrium (eq 4-1). The coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎, is related to the coupling free 
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 energy (∆𝐺𝐺𝑎𝑎𝑎𝑎) and the entropy (𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎) and enthalpy (∆𝐻𝐻𝑎𝑎𝑎𝑎) components through the relationship 
∆𝐺𝐺𝑎𝑎𝑎𝑎 = ∆𝐻𝐻𝑎𝑎𝑎𝑎 − 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 = −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅�𝑄𝑄𝑎𝑎𝑎𝑎�    (4-5) 
∆𝐺𝐺𝑎𝑎𝑎𝑎 represents a standard free energy, although the superscript “0” is removed from the designation to avoid confusion with the use of that superscript for other purposes in notation.32 The coupling entropy and enthalpy components were determined by measuring the coupling constant as a function of temperature and then fitting the data to 









Figure 4-3: Isoleucine to a valine, “hole”, mutation. 
 
 
 for a range of PEP concentrations. The data for these apparent dissociation constants as a function of PEP concentration were then fit to eq 4-3 as shown in Figure 4-4. The dissociation constants for Fru-6-P in the absence of PEP (𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 ) and for PEP in the absence of Fru-6-P (𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 ) and the allosteric coupling parameter were obtained from these fits. The data for the allosteric coupling parameters were used   
 
Figure 4-4: The log of the apparent 𝑲𝑲𝒂𝒂 for Fru-6-P as a function 
of the log of [PEP] for wild-type (filled circles), I150V (open 
circles), I153V (filled squares), and I234V (open squares) 
variants of BsPFK. 
100 
 




 Table 4-1: Ligand dissociation constants and coupling constants 
for wild-type and variant forms of B. stearothermophilus and E. 
coli PFK at 25 °C.  
 𝑲𝑲𝒊𝒊𝒂𝒂𝒐𝒐   (mM) 𝑲𝑲𝒊𝒊𝒂𝒂
𝒐𝒐   
(mM) 𝑸𝑸𝒂𝒂𝒂𝒂  ∆𝜟𝜟𝒂𝒂𝒂𝒂 (kcal/mol) 
WT-BsPFK 0.039 ± 0.002 0.0630 ± 0.004 0.0021 ± 0.0002 3.66 ± 0.06 
I150V-BsPFK 0.027 ± 0.001 0.074 ± 0.005 0.0042 ± 0.0003 3.25 ± 0.04 
I153V-BsPFK 0.0236 ± 0.0005 0.0168 ± 0.0005 0.00054 ± 0.00007 4.46 ± 0.08 
I234V-BsPFK 0.033 ± 0.002 0.057 ± 0.004 0.0024 ± 0.0002 3.58 ± 0.05 
WT-EcPFK 0.346 ± 0.009 0.28 ± 0.02 0.015 ± 0.001 2.50 ± 0.05 




Figure 4-5: The variation in the log of 𝑸𝑸𝒂𝒂𝒂𝒂 verses reciprocal 
temperature of wild-type (filled circles), I150V (open circles), 
I153V (filled squares), and I234V (open squares) variants of 
BsPFK. 
  described by a straight line within the temp range examined, signifying that there is not a detectable change in heat capacity, ∆𝐶𝐶𝑝𝑝, over this range of temperatures. The values of ∆𝐻𝐻𝑎𝑎𝑎𝑎, 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 and ∆𝐺𝐺𝑎𝑎𝑎𝑎 are listed in Table 4-2. In response to the I153V mutation the enthalpy term becomes less negative by 3.5 kcal/mol, while the entropy term becomes less negative by 2.8 kcal/mol at 25 °C. The diminished allosteric coupling in I150V-BsPFK is accompanied by a decrease in both the enthalpy (3.4 kcal/mol) and the entropy (2.0 kcal/mol) components, leading to an overall increase in compensation at 25 °C. Despite opposing effects on the allosteric  
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 Table 4-2. Parameters quantifying the inhibition of PFK from WT 
and variant forms of B. stearothermophilus and E. coli PFK by 
PEP at 25 °C. 
 
 ∆𝜟𝜟𝒂𝒂𝒂𝒂 (kcal/mol) 𝑻𝑻∆𝑻𝑻𝒂𝒂𝒂𝒂 (kcal/mol) ∆𝜟𝜟𝒂𝒂𝒂𝒂 (kcal/mol) WT-BsPFK -17.4 ± 1.3 -21.0 ± 1.3 3.66 ± 0.06 
I150V-BsPFK -20.8 ± 0.7 -23.9 ± 0.7 3.25 ± 0.04 
I153V-BsPFK -13.9 ± 1.3 -18.2 ± 1.3 4.46 ± 0.08 
I234V-BsPFK -5.3 ± 0.9 -8.9 ± 0.9 3.58 ± 0.05 
WT-EcPFK 16.2 ± 1.7 13.7 ± 1.7 2.50 ± 0.05 
L154V-EcPFK 16.2 ± 1.3 13.4 ± 1.4 2.84 ± 0.06   coupling for both I150V-BsPFK and I153V-BsPFK, the ∆𝐻𝐻𝑎𝑎𝑎𝑎 component of the allosteric coupling free energy is changed by a greater magnitude than the ∆𝑆𝑆𝑎𝑎𝑎𝑎 component in both cases. The level of compensation between ∆𝐻𝐻𝑎𝑎𝑎𝑎 and 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 at 25 °C remains the same between I234V-BsPFK and WT-BsPFK, however each component is affected by 12.1 kcal/mol. Consequently, the inhibition of I234V-BsPFK varies from WT to a greater degree at temperatures higher and lower than 25 °C. Since different thermodynamic components drive the allosteric coupling in BsPFK and EcPFK, despite being very similar enzymes otherwise, the next step was to evaluate the effect of a mutation in EcPFK analogous to the mutation that provided augmented allosteric coupling in BsPFK. In addition, the EcPFK enzyme is 
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 considered more flexible than its BsPFK counterpart and can serve in that way as a useful comparison. The variant used to explore this was L154V-EcPFK, which introduces a similar, but possibly more substantial, change than the isoleucine to valine mutation. The allosteric coupling free energy is barely augmented by 0.3 ± 0.1 kcal/mol in the L154V-EcPFK variant compared to WT-EcPFK (Figure 4-6); this difference is substantially less than that in the corresponding I153V-BsPFK mutant.  
 
Figure 4-6: The log of the apparent 𝑲𝑲𝒂𝒂 for Fru-6-P as a function 
of the log of [PEP] for wild-type (circles), and L154V (squares) 
variants of EcPFK. 
  The resulting values of 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 , 𝑄𝑄𝑎𝑎𝑎𝑎, and ∆𝐺𝐺𝑎𝑎𝑎𝑎 are presented in Table 4-1 for both L154V-EcPFK and wild-type EcPFK. A modest decrease in 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  in response to the mutation in EcPFK was observed. Unlike I153V-BsPFK, which has almost 4-fold 
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 tighter PEP binding compared to wild-type, the L154V mutation in EcPFK resulted in slightly weaker PEP binding. The same type of thermodynamic analysis completed with the BsPFK mutants above was repeated for WT-EcPFK and L154V-EcPFK. Plots of the log of 
𝑄𝑄𝑎𝑎𝑎𝑎 as a function of reciprocal temperature for both the mutant and WT-EcPFK enzymes show that there is little if any change in slope in response to the mutation, revealing no change in the enthalpy component of the coupling free energy (Figure 4-7). In addition, there is also not a significant change in the entropy term. The numerical values corresponding to ∆𝐻𝐻𝑎𝑎𝑎𝑎, 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎, and ∆𝐺𝐺𝑎𝑎𝑎𝑎 are listed in Table 4-2.   
 
Figure 4-7: The variation in the log of 𝑸𝑸𝒂𝒂𝒂𝒂 verses reciprocal 





  The BsPFK variants used in this study each contain a conservative single amino acid substitution of isoleucine to valine. From the X-ray crystallography structures of BsPFK, one can identify an extensive hydrogen-bonding network that stretches through the region between the allosteric site and the closest active site. The allosteric coupling between these two sites, termed the 22 Å interaction, was previously shown to make the strongest contribution to the overall heterotropic coupling free energy in both EcPFK110 and BsPFK98. The residues mutated to construct the cavity containing variants in BsPFK all lie between or are in proximity to the region between these sites as shown in Figure 4-8.  
 
Figure 4-8: X-ray crystallography structure showing the location 
of the I150V (green), I153V (red), and I234V (blue) mutations in 
space fill. ADP and Fru-6-P are shown in the allosteric and active 




 We postulated that the removal of a methylene group, resulting in the addition of a small cavity, would not largely alter the overall structure of the enzyme. We were curious, however, if it would allow for a change in the flexibility and stability of the BsPFK enzyme and possibly the extent of PEP inhibition. EcPFK, which is not as rigid as BsPFK and has a smaller value for ∆𝐺𝐺𝑎𝑎𝑎𝑎, serves as an interesting comparison. The magnitude of allosteric inhibition is given by the standard free energy, ∆𝐺𝐺𝑎𝑎𝑎𝑎, for the disproportionation equilibrium and each of the four species in eq 4-1 that contribute to the poise of this equilibrium are potentially altered in response to the mutation. The value for ∆𝐺𝐺𝑎𝑎𝑎𝑎 is derived from the difference between the perturbations of the free energy of formation when both ligands bind simultaneously versus the sum of the perturbations experienced by the binding of each ligand individually. In other words, the changes caused by the mutation must enhance or relieve conflict in the ternary complex in order to alter the value for ∆𝐺𝐺𝑎𝑎𝑎𝑎, thereby modifying the degree of inhibition. Two of the three mutations have a substantial effect on the allosteric coupling free energy at 25 °C. The variant I153V-BsPFK has the strongest effect represented by an almost 4-fold augmentation of inhibition and a 0.8 kcal/mol increase in the allosteric coupling free energy. Residue Ile-153 is located within an 
α-helix that passes directly between an active and allosteric binding site pair that are 22 Å away from each. Residue Ile-150 is also located within this helix, but is positioned slightly further away from the region between the binding sites. Alternatively, the mutation at this location led to a weakening of the allosteric 
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 coupling. The mutant with no effect on the inhibition of PFK by PEP at 25 °C, I234V, is located within another α-helix 12 Å away from the helix containing the other mutations. The effect on allosteric coupling as a result of the small cavity containing mutations ranges from no effect at all to substantially altering the allosteric coupling both positively and negatively. This implies that the allosteric coupling free energy is very sensitive to small changes in the enzyme’s structure. A recent study utilizing PFK from the extreme thermophile Thermus 
thermophilus (TtPFK) also probed the effect of residues in this region on PEP inhibition.135 In this study, a set of three residues were identified between the pair of Fru-6-P and PEP binding sites located 22 Å apart that when mutated to the residue found natively in BsPFK enhanced allosteric inhibition by 3 kcal/mol. One of these key residues is at position 158, and is located within the same helix as Ile-153 and Ile-150. Interestingly, each individual mutation in TtPFK increased coupling essentially additively, and by a greater extent than one would expect if a linked chain of interactions was required to propagate the allosteric signal. It was hypothesized that the entropic nature of the inhibition may explain why a localized network of interactions does not seem to provide an explanation for allosteric coupling. The entropic nature of inhibition in BsPFK may also explain why we see substantial changes in the allosteric coupling with very minor perturbations.  We were surprised that the degree of allosteric coupling was altered in response to such conservative mutations. We predicted that the changes in the allosteric coupling free energy introduced by the removal of a methylene group 
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 would be more likely due to effects on the conformational entropy as opposed to effects on the enthalpy component of the coupling free energy. Changes in the coupling entropy, 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎, term are in fact seen for all three of the BsPFK cavity containing mutants. Equal, or even more substantial changes in ∆𝐻𝐻𝑎𝑎𝑎𝑎 are also seen, however. The less negative values observed in the entropy component of the coupling seen for I153V and I234V may suggest that in these cases there are increased thermal fluctuations present in the propagation of the allosteric signal. Surprisingly, the entropy component of the coupling becomes more negative in the case of I150V, suggesting less flexibility in the transfer of the signal between binding sites. In contrast to the entropically driven allosteric coupling in BsPFK, the allosteric coupling between Fru-6-P and PEP binding sites in EcPFK is enthalpy driven, indicating the possibility that distinct mechanisms may be responsible for transmitting the allosteric signal between Fru-6-P and PEP binding sites in the two isozymes. Probing this important difference between these otherwise very similar enzymes has the potential to provide new information about the mechanisms of allosteric regulation in prokaryotic PFK in general. In addition, because the EcPFK enzyme is more flexible than the BsPFK enzyme it serves as a point of comparison for the effect of the mutations. The L154V-EcPFK mutant, which corresponds to I153V-BsPFK, also has augmented allosteric coupling, but only to a very small extent. 
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 In conclusion, multiple mutations were made to probe the effect of adding a small cavity to the structure of the entropy dominated allosteric coupling of BsPFK. Of these mutations, two altered the allosteric coupling free energy of BsPFK substantially at 25 °C, and all three had an effect on both the entropy and enthalpy components of the coupling free energy. When the mutation with the largest effect in BsPFK was made in EcPFK very little effect was seen on the allosteric coupling. These results indicate that even very small perturbations to the BsPFK enzyme can have very substantial effects on both the entropy and enthalpy components of the coupling free energy. This is interesting because the moderate thermophile BsPFK is considered a fairly rigid enzyme116,144,148,149, and we expect that the mutations make regions of the enzyme more flexible. Previous studies in the lab utilizing BsPFK demonstrated that temperature and pH also exert their influence on allosteric inhibition by changing the relative contributions made by the ∆𝐻𝐻𝑎𝑎𝑎𝑎 and 
𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 terms of the coupling free energy.42 Regardless, because the entropy and enthalpy terms do change so much, there is ample opportunity for the balance between them to also change. These changes alter the poise of the disproportionation equilibrium and affect the extent of inhibition in BsPFK, but not in the more flexible EcPFK. Perhaps the ability to so easily modify the extent of allosteric inhibition in BsPFK has served an evolutionary advantage, allowing the enzyme to quickly adapt to varying environments. It also seems that the ability to alter the efficiency of inhibition of a major metabolic pathway with relative ease would be advantageous for drug design. 
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 CHAPTER V  
PROPAGATION OF THE ALLOSTERIC SIGNAL IN PHOSPHOFRUCTOKINASE 
FROM BACILLUS STEAROTHERMOPHILUS EXAMINED BY METHYL-TROSY NMR  
Introduction  In order to isolate regions and residues of the phosphofructokinase structure from Bacillus stearothermophilus (BsPFK) that are involved in the propagation of the allosteric signal, we employed linkage analysis and methyl-TROSY NMR. Chemical shift changes, of the relevant resonance frequencies, were analyzed in response to ligand binding and formation of the ternary complex. These resonance frequencies vary in response to changes in the local magnetic environment of the nuclei and therefore small changes in structure and dynamics of a particular nucleus is readily detectable by monitoring the change in chemical shift.150 This sensitivity of the nuclei to its local magnetic environment has led to the frequent use of 2D heteroneuclear experiments to generate “fingerprints” by which protein conformational changes and ligand binding can be studied.151 Unfortunately, the utility of these traditional experiments is limited to proteins with a molecular weight of less than 50 Kda. BsPFK is a fairly large enzyme with a subunit molecular weight of 34 Kda. In its active form, the subunits form a homotetramer composed of a dimer of dimers, where opposing interfaces form the active and allosteric binding sites, with a total molecular weight of 136 Kda. 
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 The development of NMR experiments that enable the preservation of NMR signals that would otherwise rapidly decay for large protein systems152,153, including transverse relaxation-optimized spectroscopy (TROSY) coupled with the development of new selective isotope labeling strategies,154,155 has allowed for the study of increasingly larger proteins by NMR spectroscopy. A general approach that extends application to high molecular weight proteins, such as BsPFK, involves the use of 13C and protonated methyl group probes on alanine, methionine, isoleucine, leucine and/or valine residues in an otherwise highly deuterated environment.155-
157 Selection of this labeling scheme is motivated firstly by the fact that methyl groups are prevalent throughout the enzyme, including hydrophobic cores and at molecular interfaces, thereby serving as well distributed internal reporters of dynamics and structure.158 Secondly, exceptional spectral sensitivity results from the three equivalent protons in each methyl group, coupled with the rapid rotation of the methyl about its threefold symmetry axis and its localization to flexible ends of side chains. Furthermore, the inherent spin physics of a methyl group enables the preservation of NMR signals, even in large biomolecular systems, via a methyl-TROSY effect that manifests in 13C–1H heteronuclear multiple quantum correlation (HMQC) spectra.152 TROSY selects only the sharpest doublet component of the signal. This causes half of the signal to be lost; however, it also accounts for a large gain in signal to noise ratio which is needed when studying large proteins via NMR. This investigation utilizes methyl-TROSY NMR to examine the four enzyme species involved in PEP inhibition of BsPFK, the enzyme that catalyzes the 
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 phosphorylation of fructose-6-phosphate (Fru-6-P) by MgATP to produce fructose-1,6-bisphosphate. In this highly allosterically regulated first committed step of glycolysis, BsPFK is allosterically inhibited by the K-type effector phosphoenol-pyruvate (PEP). Paramount to the success of any NMR study is appropriately labeling your protein of interest. The labeling strategy used for BsPFK incorporated isoleucines which were selectively 13C labeled and protonated at the δ-methyl group in an otherwise 12C and deuterated enzyme. The labeling was accomplished by adding isotopically labeled α-ketobutyrate, a metabolic precursor to isoleucine biosynthesis, to the cell culture prior to induction. Figure 5-1 shows the overall reaction by which 2-keto-3-d2-4-13C-butyratebutyrate, [12C, 2H] D-glucose, and 
15NH4Cl are incorporated into the isoleucine residues of BsPFK. By measuring the    
 
Figure 5-1: Structure of the labeled α-ketobutyrate precursor, 
and how each labeled component of the minimal media is 
incorporated into the isoleucine residues of [U-15N,2H];Ileδ1-
[13CH3] BsPFK. 
  perturbations in NMR chemical shifts upon substrate and inhibitor binding methyl groups can serve as local reporters on the allosteric coupling. These results are especially relevant when combined with previous studies in the lab which have 
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 identified regions of the enzyme predicted to contribute to the coupling entropy parameter.117  When describing the nature and magnitude of the allosteric effect between the two ligands Fru-6-P and PEP, all possible ligation states of the enzyme must be considered. BsPFK (E) is free enzyme. BsPFK:F6P (EA) and PEP:BsPFK (YE) are the two binary complexes and PEP:BsPFK:F6P (YEA) is the ternary complex. The effect the inhibitor PEP has on the subsequent binding of substrate Fru-6-P to the enzyme, and the equivalent reciprocal effect of Fru-6-P on the binding of PEP, can be quantified by the coupling constant, 𝑄𝑄𝑎𝑎𝑎𝑎. This coupling constant is defined by a ratio of thermodynamic dissociation constants for Fru-6-P and PEP using the following equation: 
𝑄𝑄𝑎𝑎𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜𝐾𝐾𝑖𝑖𝑎𝑎∞ (5-1) where, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 and 𝐾𝐾𝑖𝑖𝑎𝑎∞ are the dissociation constants for Fru-6-P (A) in the absence and saturating presence of PEP (Y), respectively. Analogously, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  and 𝐾𝐾𝑖𝑖𝑎𝑎∞ are the dissociation constants for PEP in the absence and saturating presence of Fru-6-P, respectively. By substituting the definitions for the dissociation constants into this equation, it can be shown that the coupling constant serves as an equilibrium constant between the four species in the following disproportionation reaction: [𝐸𝐸𝐴𝐴] + [𝑌𝑌𝐸𝐸] 𝑄𝑄𝑎𝑎𝑎𝑎�� [𝐸𝐸] + [𝑌𝑌𝐸𝐸𝐴𝐴] (5-2) where, the left side of the equilibrium contains the two binary complexes and the right side encompasses free enzyme and the ternary complex. For this reaction, the 
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 standard allosteric coupling free energy (∆𝐺𝐺𝑎𝑎𝑎𝑎) can be defined in terms of either the equilibrium constant or its enthalpy and entropy components as follows: 
∆𝐺𝐺𝑎𝑎𝑎𝑎 = −𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅�𝑄𝑄𝑎𝑎𝑎𝑎� = ∆𝐻𝐻𝑎𝑎𝑎𝑎 − 𝑅𝑅∆𝑆𝑆𝑎𝑎𝑎𝑎 (5-3) where, R is the gas constant and T is the absolute temperature in Kelvin. By past convention, the superscript “0” is omitted to avoid confusion with the meaning of the superscripts appearing in eq 5-1 and the scheme in Figure 1-2.32 In an effort to ascertain the molecular basis for the inhibition by PEP, for which ∆𝐺𝐺𝑎𝑎𝑎𝑎> 0 by definition, one must consider the four enzyme species depicted in eq 5-2 and how their differences might ultimately generate the thermodynamic values of ∆𝐻𝐻𝑎𝑎𝑎𝑎 and 
∆𝑆𝑆𝑎𝑎𝑎𝑎 as shown in eq 5-3.  The present study attempts to identify regions of enzyme that likely contribute to the coupling free energy. More specifically, Methyl-TROSY HMQC experiments were conducted with [U-2H,15N]-BsPFK specifically labeled with Ileδ1-[13C,1H3] in order to gain more structural information about BsPFK in all four states of ligation relevant to the allosteric coupling. As a result of these experiments, specific residues of the enzyme where structural conflicts arise upon the binding of both ligands simultaneously are identified. Mapping these “interesting” residues back to the crystal structure has allowed specific regions of the enzyme involved in the propagation of the allosteric signal to be identified.     
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 Materials and Methods  
 
Materials 
 All chemical reagents used in buffers for protein purification, enzymatic assays, and NMR experiments were of analytical grade and were purchased from Sigma-Aldrich (St. Louis, MO), Fisher Scientific (Fair Lawn, NJ), or Research Products International (Mt. Prospect, IL) unless otherwise noted. Deionized distilled water was used throughout. Lyophilized creatine kinase, the ammonium sulfate suspension of glycerol-3-phosphate dehydrogenase, and the potassium salt of phosphoenol-pyruvate were purchased from Roche (Indianapolis, IN). The ammonium sulfate suspensions of aldolase, the ammonium sulfate suspension of triosephosphate isomerase, the disodium salt of fructose-6-phosphate, and the disodium salt of phosphocreatine were purchased from Sigma-Aldrich (St. Louis, MO). The coupling enzymes were extensively dialyzed against 50 mM EPPES pH 8.0, 100 mM KCl, 5 mM MgCl2, and 0.1 mM EDTA before use. NADH and DTT were purchased from Research Products International (Mt. Prospect, IL). Mimetic Blue 1 A6XL resin used in protein purification was purchased from Promatic BioSciences (Rockville, MD). The Mono-Q HR anion exchange column used in protein purification was purchased prepacked for FPLC use from Pharmacia (currently GE Healthcare, Uppsala, Sweden). Amicon Ultra centrifugal filter units (spin concentrators) were from Millipore Corporation (Billerica, MA) and poly(ethylene glycol)-3000 was from Sigma-Aldrich (St. Louis, MO). Minimal media was made 
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 using potassium phosphate, monobasic, and sodium phosphate, dibasic, from EMD Chemicals (Gibbsown, NJ). Additional components of the minimal media include D-glucose from Macron Chemicals (Center Valley, PA), magnesium sulfate and ferrous sulfate from Fisher Scientific (Fair Lawn, NJ), thiamine hydrochloride and calcium chloride dihydrate from Sigma-Aldrich (St. Louis, MO), and ammonium chloride from Acros Organics (NJ). Deuterated MES-d13 was from Sigma-Aldrich (St. Louis, MO). Ammonium chloride (15N, 99%), L-isoleucine (15N, 98%), L-isoleucine(13C6,99%;15N, 99%), α-ketobutyric acid, sodium salt (CH3-13C, 99%), D-glucose (1,2,3,4,5,6,6-D7,97-98%), D-glucose (U-13C6,99%; 1,2,3,4,5,6,6-D7,97-98%) and deuterium oxide (D, 99.9%) are from Cambridge Isotope Laboratories, INC (Andover, MA). Shigemi NMR tubes were purchased from Shigemi, Inc. (Allison Park, PA) and were used for all NMR experiments. 
 
Protein Expression and Purification of Isotopically Labeled Wild-type BsPFK The plasmid pBR322/BsPFK118 contains the gene for BsPFK behind the native Bacillus stearothermophilus promoter. This plasmid was modified to place the BsPFK gene behind an inducible lac promoter in pALTER-1, it should be noted that an inducible plasmid was necessary to express the proteins in minimal media. BsPFK was expressed in E. coli RL257A cells, which are a T1 bacteriophage resistant derivation of RL257 cells119, which intern are lacking both the pfkA and 
pfkB genes. RL259A cells were made by P1 transduction159 using RL257 cells as the recipient strain and RY12459 cells as a donor strain. RY12459 cells were obtained 
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 from Ry Young (Texas A&M University, College Station, TX) and are a derivative of MC4100160 that contain a tonA gene disruption within a kanamysin cassette.  Protein expression of the [U-15N,2H];Ileδ1-[13CH3]-BsPFK was performed as described previously by Tugarinov, V. et. al., with a few minor modifications.155 Following heat shock transformation, cells were picked from a single bacterial colony that was grown on solid Lysogeny Broth (LB)/tet/H2O media (Tryptone 10 g/L, yeast extract 5 g/L, and Sodium Chloride 10 g/L, tetracycline 15 μg/mL). These cells were transferred to a 5 mL culture of LB/tet/H2O media and allowed to grow in a shaking incubator at 37 °C until the cell density reached an OD600 of 0.7 - 0.8 (4 - 6 hours).  The 5 mL culture was spun down with a speed of 1,200 × g at room temperature and the pellet was gently resuspended in 1 mL of M9/H2O media (0.048 M Na2HPO4, 0.022 M KH2PO4, 9 mM NaCl, 19 mM NH4Cl, 0.2 % glucose, 2 mM MgSO4, 100 µM CaCl2, 10 µg/mL thiamine, 10 µg/ml FeSO4, 15 µg/mL tetracycline) which contained unlabeled glucose and NH4Cl.  Aliquots of the resuspension were added to 20 mL of the unlabeled M9/H2O media until the starting OD600 was between 0.05 and 0.1. The culture was grown until the OD600 reached 0.6, which took between 8 - 10 hours. The culture was then centrifuged and resuspended in 100 mL of labeled M9/D2O media (containing [2H,13C]-glucose and 15NH4Cl) so that the beginning OD600 was 0.1.  These cells were grown until the OD600 was between 0.4 - 0.5 (8 - 10 hours), then the cells were diluted to 200 mL by the addition of 100 mL labeled M9/D2O media and were again grown until the OD600 reached 0.4 - 0.5 (4 - 6 hours).  At this time the culture was diluted with labeled M9/D2O media to a 
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 volume that equaled 1 L once the α-ketobutyrate was added and allowed to grow until the OD600 was 0.25 (4 - 6 hours).  At this time, 70 mg/L of [3-2H2],13C  α-ketobutyrate was added to the culture. Following a previously established protocol, [3-1H],13C  α-ketobutyrate was deuterated by incubating the 13C α-ketobutyrate at pH 10.5 in D2O for 12 - 14 hours prior to its addition.156 The culture was allowed to grow for approximately one hour until the OD600 was between 0.3 - 0.4. Protein expression was induced with the addition of 1 mM IPTG and the cells were allowed to grow for 8 hours. The final OD600 was between 0.7 - 1.0.  For [U-15N,2H]; Ileδ1-[13CH3]-BsPFK, the same procedure was followed with the following exceptions: minimal media was prepared with 14NH4Cl instead of 
15NH4Cl, and Ile-[15N] was added to the media instead of the α-ketobutyrate precursor. For [U-15N,2H,]; Ile-[15N, 13C]-BsPFK the same procedure was followed except Ile-[15N, 13C] was added to the media instead of the α-ketobutyrate precursor. For [U-2H,15N,13C]-BsPFK minimal media was prepared with D-[2H, 13C] glucose and 15NH4Cl and no selective labeling of isoleucine methyl groups was performed. Upon completion of growth, cells were harvested from the media by centrifugation and frozen at -20 °C for at least 12 hours before resuspension in purification buffer (10 mM Tris-HCl pH 8.0 and 1 mM EDTA) and sonication in a Fisher 550 Sonic Dismemberator at 0 °C in 15 second pulses at setting 6 for 12 minutes or until the OD600 is no longer decreasing. The crude lysate was centrifuged at 22,500×g for 30 minutes at 4 °C. The clarified supernatant was incubated in a 
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 water bath at 70 °C for 15 minutes, cooled on ice for 15 minutes, and centrifuged again for 30 minutes at 4 °C. The BsPFK supernatant was diluted to 1 L and loaded onto a Mimetic Blue 1 A6XL column that was equilibrated with purification buffer. The column was washed with 1 L of purification buffer, and the enzyme was eluted with a 600mL 0 - 1.5M NaCl gradient. Enzyme containing fractions were pooled and dialyzed into 20 mM Tris-HCl pH 8.5 and loaded onto a Pharmacia Mono-Q HR anion exchange column that had been equilibrated with the same buffer. The enzymes were eluted with a 200 mL 0 - 1 M NaCl gradient and PFK containing fractions were combined, concentrated, then dialyzed into MES Buffer (10mM MES, pH 6.0). Concentrated enzyme was further dialyzed and stored in MES-d13/D2O Buffer (10 mM deuterated MES pH 6.0 and 0.02 % NaN3) at 4 °C. The final enzyme was determined to be pure by SDS-PAGE and the concentration was ascertained 
using the absorbance at 280 nm (ε = 18910 M-1cm-1). The final enzyme concentrations achieved for NMR experiments were between 0.4 - 0.5 mM in monomer. Approximately 325 μL of protein was added to a Shigemi NMR tube.  Fru-6-P and PEP solutions that were added to the NMR protein samples were diluted in MES/D2O buffer and were made as concentrated as possible in order to add the smallest possible volume. 
 
Generation of the Four Enzyme-Ligand Species  To generate the PEP-BsPFK species, 50 mM PEP was added to BsPFK.  For the generation of the substrate bound complex, 10 mM F6P was added to BsPFK.  
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 The ternary complex was mixed with 10 mM Fru-6-P and 50 mM PEP to generate PEP:BsPFK:Fru-6-P. Based on the ligand dissociation constants and the allosteric coupling constant at 37 °C and pH 6.0, less than 2 % of other species were present. The ligand dissociation constants were determined using steady-state fluorescence assays with a tryptophan-shifted mutant. These assays were performed in the absence of turnover and the second substrate, ATP, to match the conditions of the enzyme during the NMR experiments. In addition, NMR titrations confirmed that spectra represent saturated complexes where indicated.   
Methyl-TROSY NMR Spectroscopy  Methyl-TROSY experiments were performed on either a Bruker 600 MHz, or 800 MHz spectrometer, both instruments equipped with a cryo-probe. Two-dimensional 1H-13C HMQC methyl correlation experiments were acquired on samples of [U-15N,2H]; Ileδ1-[13CH3]-BsPFK using the pulse schemes described previously.152 The temperature was set to 37 °C for all experiments.  NMR data were processed and analyzed with TopSpin and analyzed using Sparky.  
Resonance Assignments Isoleucine assignments were determined through 3D HMQC-NOESY experiments with [U-15N,2H]; Ileδ1-[13CH3]-BsPFK and complementary HNCA and HNCOCA experiments with [U-2H,15N,13C] BsPFK. In addition a 2D 1H-15N TROSY 
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 spectrum of [U-2H];Ile-[15N]-BsPFK and triple resonance experiments with [U-15N, 
2H];Ile-[15N, 13C]-BsPFK confirmed the assignments.  
 
Steady-State Kinetic Assays  Activity measurements for BsPFK were carried out using a coupled enzyme system121,122 in a 0.6 mL reaction volume of either 50mM EPPS buffer (pH 8.0, 25 °C) or 10 mM MES buffer (pH 6.0, 37 °C), additionally containing 5 mM MgCl2, 100 mM KCl, 0.1 mM EDTA, 2 mM DTT, 0.2 mM NADH, 3 mM ATP, 250 μg aldolase, 50 
μg of glycerol-3-phosphate dehydrogenase, and 5 μg of triosephosphate isomerase. 40 μg/mL of creatine kinase and 4 mM phosphocreatine were added as an ATP regenerating system to avoid the accumulation of MgADP, which is an activator. Temperature was controlled using a NESLab RTE-111 circulating water bath. Fru-6-P and PEP were added at varied concentrations as indicated. Assays were started 
by the addition of 10 μL of appropriately diluted PFK and the reaction was monitored as the absorbance at 340 nm decreased over time. The rate of the reaction was measured on Beckman Series 600 spectrophotometers using a linear regression calculation to convert change in absorbance at 340 nm to PFK activity. One unit of PFK activity is described as the amount of enzyme needed to produce 1 
μmol of fructose-1,6-bisphosphate per minute.    
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 Kinetic Data Analysis  Data were fit using the non-linear least-squares fitting analysis option in Kaleidagraph software version 4.5 (Synergy). For the steady-state kinetic assays the initial velocity data were plotted against concentration of Fru-6-P and fit to the Hill equation8: 
𝑣𝑣 = 𝑉𝑉[𝐴𝐴]𝑛𝑛𝐻𝐻
𝐾𝐾𝑎𝑎
𝑛𝑛𝐻𝐻 + [𝐴𝐴]𝑛𝑛𝐻𝐻 (5-4) where, 𝑣𝑣 is the initial velocity, [𝐴𝐴] is the concentration of the substrate Fru-6-P, 𝑉𝑉 is the maximal velocity, and 𝑅𝑅𝐻𝐻  is the Hill coefficient. 𝐾𝐾𝑎𝑎 is defined as the concentration of Fru-6-P at which the enzyme’s activity is half-maximal. Assuming rapid equilibrium for Fru-6-P, which was shown to be valid in EcPFK using a steady-state kinetic method, 𝐾𝐾𝑎𝑎 is equivalent to the dissociation constant for Fru-6-P from the binary enzyme-substrate complex34,101.  Values of  𝐾𝐾𝑎𝑎 obtained from the initial velocity experiments were plotted against the concentration of opposing ligand and fit according to 
𝐾𝐾𝑎𝑎 = 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 � 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + [𝑌𝑌]𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜 + 𝑄𝑄𝑎𝑎𝑎𝑎[𝑌𝑌]� (5-5) where 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for Fru-6-P in the absence of PEP, 𝐾𝐾𝑖𝑖𝑎𝑎𝑜𝑜  is the dissociation constant for PEP in the absence of Fru-6-P, and 𝑄𝑄𝑎𝑎𝑎𝑎 is the coupling coefficient.32,33,123 𝑄𝑄𝑎𝑎𝑎𝑎 describes the effect of the allosteric effector on the binding of the substrate, and is defined in eq 5-1.   
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 Results  




Figure 5-2: [U-15N,2H];Ileδ1-[13CH3] labeling of BsPFK provided 
excellent coverage of the enzyme and well resolved 2D spectra. 
A) X-ray crystal structure of the BsPFK monomer with all 30 
isoleucine residues represented by spheres. Yellow spheres are 
isoleucines we were able to assign, and black spheres are 
isoleucines that remain unassigned. ADP is shown in the 
allosteric site in blue, and Fru-6-P is shown in the active site in 
red. B) Methy-TROSY spectrum (37 °C; pH6.0; 600MHz; 10% 
D20/90% H20) C) 1H-15N TROSY spectrum (37 °C; pH6.0; 
800MHz; 10% D20/90% H20). 
 
 
 Specific activity, apparent ligand dissociation constants, and the allosteric coupling parameters for the isotopically labeled enzymes were comparable to their unlabeled counterparts, as shown in Figures 5-3A and B, and in Tables 5-1 and 5-2.  
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Figure 5-3: Allosteric couplings for unlabeled and isotopically 
labeled BsPFK variants at A) 37 °C and pH 6.0 and B) 25 °C and 
pH 8.0. Filled circles are unlabeled BsPFK, open circles are [U-
15N], [13C,1H3]-ILE BsPFK, filled squares are [U-2H,15N,13C] BsPFK, 
open squares are [U-2H], [15N]-ILE BsPFK, and triangles are [U-
2H,15N], [13C]-ILE BsPFK. 
 
 










 Table 5-1:  Allosteric coupling parameters for unlabeled and the 




𝒐𝒐   
(µM) 
𝑲𝑲𝒊𝒊𝒂𝒂





(kcal/mol) Unlabeled 39 ± 2 63 ± 4 0.0021 ± 0.0002 3.65 ± 0.02 [U-15N,2H];Ileδ1-[13CH3] 34 ± 2 40 ± 2 0.0022 ± 0.0002 3.63 ± 0.02 [U-2H,15N,13C] 44 ± 3 49 ± 4 0.0021 ± 0.0003 3.65 ± 0.04 [U-2H];Ile-[15N] 30 ± 2 33 ± 2 0.0021 ± 0.0001 3.65 ± 0.01 [U-2H,15N];Ile-[13C] 41 ± 1 56 ± 2 0.0022 ± 0.0002 3.63 ± 0.02    
Table 5-2:  Allosteric coupling parameters for unlabeled and the 




𝒐𝒐   
(µM) 
𝑲𝑲𝒊𝒊𝒂𝒂





(kcal/mol) Unlabeled 35 ± 2 48 ± 7 0.010 ± 0.002 2.728 ± 0.005 [U-15N,2H]; Ileδ1-[13CH3] 32 ± 1 55 ± 4 0.008 ± 0.001 2.861 ± 0.003 [U-2H,15N,13C] 35 ± 4 42 ± 7 0.012 ± 0.002 2.620 ± 0.004 [U-2H]; Ile-[15N] 35 ± 4   82 ± 14 0.011 ± 0.001 2.672 ± 0.002 [U-2H,15N]; Ile-[13C] 31 ± 1 50 ± 3 0.011 ± 0.001 2.672 ± 0.002    In chemical shift correlation maps of 13C and 1H all 30 isoleucines are well resolved (Figure 5-2B). These spectral maps reveal several cross peaks with chemical shifts unique to each state of ligation indicating unique structures for each 
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 of the enzyme forms. Apo BsPFK and F6P-bound BsPFK spectra are similar to each other whereas the PEP-bound BsPFK spectrum has numerous dissimilar peaks. Distinct peaks, not seen in any other spectra, are present in the spectrum of the ternary complex. In addition, the amide backbones of all 320 amino acids are 15N labeled in [U-15N,2H]; Ileδ1-[13CH3]-BsPFK and Figure 5-2C shows a 1H-15N TROSY spectrum with decent dispersion of resonances. However, because the entire backbone is 15N labeled, there is quite a bit of crowding in the 1H-15N TROSY. Both 2D spectra indicate the enzyme is well folded under the conditions of the experiments, which was confirmed by the sample remaining fully active throughout the experiments. Complementary HNCA and HN(CO)CA experiments with [U-2H,15N,13C]-BsPFK were used to assign the resonances corresponding to the isoleucines in the 




Figure 5-4: Methyl-TROSY spectra (37 °C; pH6.0; 600MHz; 10% 
D20/90% H20) of A) unligated, B) Fru-6-P bound, C) PEP bound 
and D) the ternary complex BsPFK with assigned isoleucine 
residues indicated. 
  was assigned in the 1H-15N TROSY, but was unable to be transferred to the methyl-TROSY spectrum. Of the remaining 12 unassigned isoleucines, at least eight appear 
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 to be buried and were likely unable to undergo the H/D exchange with solvent required to be NMR visible in 1H-15N TROSY experiments.  Fortunately, the Fru-6-P binding process and the formation of the ternary complex by either order of ligand addition are in the fast exchange regime, allowing us to see resonances move across the magnetic field in response to an increase in ligand concentration. Resonance assignments were transferred to the ligated forms of the enzyme using these titrations as demonstrated in Figure 5-5 using Fru-6-P.  
 
 
Figure 5-5: A) Overlay of methyl-TROSY spectra (37 °C; pH6.0; 
800MHz; 10% D20/90% H20) with Fru-6-P concentrations 
ranging from 0 (red) to 10 mM (Purple). B) Close up of boxed 
region of panel A. Arrows indicate the direction of chemical shift 
perturbation in response to increasing ligand concentration.    
131 
 
 To distinguish chemical shift changes involved in the allosteric inhibition of BsPFK, it was essential to first determine the chemical shift values for each ligation state of the enzyme that contributes to the disproportionation equilibrium reaction shown in eq 5-2. The coupling free energy value can further be described in terms of the free energy of formation for the products minus the free energy of formation for the reactants33: 
∆𝐺𝐺𝑎𝑎𝑎𝑎 = (𝐺𝐺𝑌𝑌𝑌𝑌𝑌𝑌 + 𝐺𝐺𝑌𝑌) − (𝐺𝐺𝑌𝑌𝑌𝑌 + 𝐺𝐺𝑌𝑌𝑌𝑌) (5-6) To simplify the equation in terms of free enzyme, subtracting the 𝐺𝐺𝑌𝑌  term from both sides of the equation gives a simple rearrangement:  ∆𝐺𝐺𝑎𝑎𝑎𝑎 = 𝛿𝛿𝐺𝐺𝑌𝑌𝑌𝑌𝑌𝑌 − (𝛿𝛿𝐺𝐺𝑌𝑌𝑌𝑌 + 𝛿𝛿𝐺𝐺𝑌𝑌𝑌𝑌) (5-7) 
where, the lower case delta (δ) signifies the differences between the free energy of formation of the indicated ligated enzyme and that for free enzyme. For example, the value of 𝛿𝛿𝐺𝐺𝑌𝑌𝑌𝑌𝑌𝑌 is equal to 𝐺𝐺𝑌𝑌𝑌𝑌𝑌𝑌 − 𝐺𝐺𝑌𝑌  (the difference in the free energy of formation of YEA compared to that of free enzyme) so that the perturbations in free energy arising from the binding of both A and Y simultaneously to the enzyme are described by this component. When this value is equal to the summation of the perturbations that occur when the ligands bind individually, ∆𝐺𝐺𝑎𝑎𝑎𝑎 equals zero, and by definition there is no allosteric effect. Rather, inhibition or activation occurs when these values are not equal to each other.  The same can be said for coupling enthalpy and coupling entropy: 
∆𝐻𝐻𝑎𝑎𝑎𝑎 = 𝛿𝛿𝐻𝐻𝑌𝑌𝑌𝑌𝑌𝑌 − (𝛿𝛿𝐻𝐻𝑌𝑌𝑌𝑌 + 𝛿𝛿𝐻𝐻𝑌𝑌𝑌𝑌) (5-8) 
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  ∆𝑆𝑆𝑎𝑎𝑎𝑎 = 𝛿𝛿𝑆𝑆𝑌𝑌𝑌𝑌𝑌𝑌 − (𝛿𝛿𝑆𝑆𝑌𝑌𝑌𝑌 + 𝛿𝛿𝑆𝑆𝑌𝑌𝑌𝑌)  (5-9) The change in chemical shift in respect to free enzyme for each of the ligated species was examined to find local regions within the enzyme that may be part of the allosteric pathway in BsPFK. These regions of interest can be found by comparing the differences in chemical shifts when the ligands bind simultaneously to the enzyme versus the summation of chemical shifts when the ligands bind individually. As chemical shift perturbations are not thermodynamic values, care must be taken in their interpretation. However, we can qualitatively divide the 17 residues we could assign into three categories based on whether the degree of chemical shifts are substantial and whether the shifts appear to be additive in respect to the ternary complex, as demonstrated in Figures 5-6 and 5-7. Residues were said to not have substantial perturbations in response to ligand binding if the chemical shift difference between the apo form and any of the three bound forms did not exceed 20% of the largest chemical shift perturbation in either the 1H and 









 Table 5-3: Chemical shift δ[EA], δ[YE], δ[YEA] and δ[YEA] - (δ[EA] 
+ δ[YE]) in the 1H and 13C dimensions for Ile residues. Bold 
numbers are those shifts qualitatively considered substantial.  
 
Residue 
1H (ppm) 13C (ppm) 
δ[EA] δ[YE] δ[YEA] δ[YEA] - (δ[EA] 
+ δ[YE]) δ[EA] δ[YE] δ[YEA] 
δ[YEA] - (δ[EA] 
+ δ[YE]) 
Ile-4 -0.004 -0.001 0.001 0.006 0.005 0.018 0.020 -0.003 
Ile-20 0.008 0.028 0.019 -0.017 0.025 -0.398 0.022 0.395 
Ile-28 -0.010 0.169 -0.049 -0.208 0.243 1.364 0.287 -1.320 
Ile-45 - - - - - - - - 
Ile-49 0.002 0.010 0.039 0.027 0.030 -0.210 -0.170 0.010 
Ile-60 - - - - - - - - 
Ile-61 - - - - - - - - 
Ile-67 -0.008 0.209 0.209 0.008 0.015 0.136 0.286 0.135 
Ile-86 0.014 0.010 0.011 -0.013 -0.003 0.002 0.011 0.012 
Ile-94 0.000 0.010 0.016 0.006 0.028 0.116 0.139 -0.005 
Ile-100 - - - - - - - - 
Ile-126 -0.016 -0.059 -0.005 0.070 0.065 -0.444 0.215 0.594 
Ile-130 -0.012 -0.029 -0.019 0.022 0.015 -0.120 -0.164 -0.059 
Ile-137 -0.030 0.014 -0.003 0.013 -0.273 0.691 0.002 -0.416 
Ile-147 -0.034 0.012 -0.033 -0.011 -0.046 -0.160 -0.272 -0.066 
Ile-150 -0.003 -0.154 -0.157 0.000 0.032 0.320 0.158 -0.194 
Ile-153 -0.007 -0.015 -0.010 0.012 -0.021 0.031 0.080 0.070 
Ile-166 -0.005 -0.041 0.007 0.053 0.024 -0.366 0.020 0.362 
Ile-176 -0.037 -0.025 -0.002 0.060 0.077 0.491 0.240 -0.328 
Ile-189 - - - - - - - - 
Ile-191 - - - - - - - - 
Ile-202 -0.019 0.006 -0.022 -0.009 -0.135 -0.161 -0.192 0.104 
Ile-217 - - - - - - - - 
Ile-218 - - - - - - - - 
Ile-219 - - - - - - - - 
Ile-234 - - - - - - - - 
Ile-286 -0.024 -0.077 -0.065 0.036 -0.059 -0.312 -0.376 -0.005 
Ile-296 - - - - - - - - 
Ile-307 - - - - - - - - 
Ile-320 - - - - - - - - 
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Figure 5-6: Some resonances do not shift, while others shift in 
either an additive or non-additive manner. A) Ile-4 is an 
example of a resonance that has the same chemical shift in the 
unligated and all three ligated forms. B) Ile-147 is an example of 
a resonance that shifts in an additive manner. Vectors represent 
the change in chemical shift upon binding of Fru-6-P (red), PEP 
(blue) or both simultaneously (purple). When arrows are not 
present the chemical shift is unchanged between the ligated and 







Figure 5-7: Ile-20, Ile-28, Ile-126, Ile-137, Ile-166 and Ile-176 
chemical shifts are perturbed in a non-additive manner. Vectors 
represent the change in chemical shift upon binding of Fru-6-P 
(red), PEP (blue) or both simultaneously (purple). When arrows 
are not present the chemical shift is unchanged between the 
ligated and unligated form. 
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Figure 5-8: A) 13C and B) 1H chemical shift perturbations of Ile 
methyl groups of BsPFK in response to the binding of Fru-6-P 
(red), PEP(blue) and both simultaneously (purple) for those 
residues which had at least one chemical shift perturbation 











Figure 5-9: Two views of the BsPFK monomer displaying the 
locations of isoleucine residues with no shifts (pink), Additive 
shifts (yellow), and non-additive shifts (green). ADP is shown in 
the allosteric site in blue, and Fru-6-P is shown in the active site 
in red. 
 
 they are also not likely involved in the allosteric inhibition of BsPFK. Positions Ile-20, Ile-28, Ile-126, Ile-137, Ile-166 and Ile-176 possess the greatest difference in the comparison of chemical shifts between the ternary complex and the summation of the binary complexes. It is at these residues, where a conflict is reported in 
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 response to the binding of both ligands simultaneously, that we predict the allosteric signal for inhibition is being transferred.  
 
Discussion 
 Perturbations to the enzyme, reported by chemical shifts, can be qualitatively related to the energetics of allosteric coupling between Fru-6-P and PEP by elaborating on ∆𝐺𝐺𝑎𝑎𝑎𝑎 as described previously.33 In re-evaluating the disproportionation equilibrium equation, it is the contrast between the summation of chemical potentials on the left side of the equation and the summation of the right side that determines the value of ∆𝐺𝐺𝑎𝑎𝑎𝑎. This demonstrates the necessity to include structural information on all four species, with focus on changes introduced to free enzyme, in order to interpret any structural changes in the context of allosteric inhibition. The residues identified as contributing to the coupling free energy, by perturbations in their chemical shift, are located generally in the regions near the two interfaces and directly between the substrate and effector binding sites. Four isoleucines, Ile-20, Ile-28, Ile-126 and Ile-137 lie between a pair of binding sites that are 30 Å away from each other. Interestingly, Ile-28 is the furthest away from the region between the binding sites and seems to have the strongest effect on the allosteric coupling of all of the identified residues. The other two isoleucine residues proposed to be involved in the propagation of the allosteric signal are Ile-
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 166 and Ile-176 and both fall between another pair of binding sites that are located 32 Å apart. This implies the lack of a single discrete structural pathway by which the allosteric signal is propagated. Ile-153, which is located between the binding sites 22 Å apart, does not seem to experience structural changes involved in the propagating of the allosteric signal. We know that coupling entropy, as opposed to coupling enthalpy, is the driving force for inhibition in BsPFK42 suggesting that factors impact the transmission of the allosteric signal, such as changes to conformational dynamics, which may not be detected with this analysis. The conservative mutation of Ile-153 to a valine has an almost 4-fold effect on allosteric inhibition (Chapter 4), providing further evidence that this residue is involved in a way not accounted for by the NMR structural data. Overall, PEP appears to have a more substantial effect on the structure of BsPFK than Fru-6-P, which is agreement with the crystal structures.107 In many of the non-additive cases where PEP has a large effect on the chemical shift the Fru-6-P bound complex has a chemical shift quite similar to the apo form of the enzyme. In these cases there is a conflict within the enzyme not allowing the system to adjust for the energy released by PEP binding in same way it does when Fru-6-P is also bound. The allosteric effect, which is characterized by as a loss in binding energy, may result from these conflicts.  Previous work in our lab identified regions of the BsPFK enzyme that likely contribute to the entropy component of the coupling free energy.117 This was accomplished by measuring the rotational correlation time of engineered 
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 fluorescent tryptophan probes throughout the enzyme under all four ligation states. Namely, the positions identified were 164 and 240. When these residues, which are expected to contribute to the entropy component of the coupling free energy, are mapped on to the structure you see that they are isolated to a single region probed by those experiments (Figure 5-10).  
 
 
Figure 5-10: BsPFK monomer showing the locations of 
isoleucine residues with non-additive shifts (Green) and the 
residues identified previously by fluorescence spectroscopy 
(Orange). ADP is shown in the allosteric site in blue, and Fru-6-P 
is shown in the active site in red. 
 
 
 It is of future interest to use the methyl probes and the power of NMR spectroscopy to further explore the dynamics and more fully characterize all of the regions and interactions of the enzyme that contribute to the entropy component of the coupling free energy. Changes in the linewidth and intensities are seen between the ligation states for several of the isoleucine residues in our study, indicating that dynamics may be present on the ms-µs time scale. Relaxation dispersion experiments need to be performed to further probe these internal dynamics 
142 
 
 involved in propagating the allosteric signal between binding sites in BsPFK. In addition, experiments probing side chain dynamics on a faster time scale may also provide additional information on how the allosteric effect is propagated in BsPFK.  
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 CHAPTER VI  
SUMMARY  Phosphofructokinase (PFK) from both Bacillus stearothermophilus (BsPFK) and Escherichia coli (EcPFK) is allosterically inhibited by downstream glycolytic pathway component phosphoenol-pyruvate (PEP). A comparison between EcPFK and BsPFK shows an overall conservation in structure and high sequence identity. The allosteric coupling free energy, 𝛥𝛥𝐺𝐺𝑎𝑎𝑎𝑎, describes the coupling in PFK between substrate, fructose-6-phosphate (Fru-6-P), and inhibitor, PEP.32,33 Using an energetics based allosteric linkage framework , as derived in Chapter I, 𝛥𝛥𝐺𝐺𝑎𝑎𝑎𝑎  is the coupling free energy for the disproportionation equilibrium below. PEP:PFK + PFK:Fru-6-P ⟷ PFK + PEP:PFK:Fru-6-P (6-1) This equilibrium is the focus for our understanding of allosteric regulation at the molecular level. The linked function approach allows us to interpret perturbations to the enzyme in way that distinguishes changes due to the binding of the ligands individually to the changes that allow the enzyme to compensate for the simultaneous binding of two ligands. The coupling free energy can further be defined in terms of its entropy (𝑅𝑅𝛥𝛥𝑆𝑆𝑎𝑎𝑎𝑎) and enthalpy components (𝛥𝛥𝐻𝐻𝑎𝑎𝑎𝑎) using the following relationship: 
𝛥𝛥𝐺𝐺𝑎𝑎𝑎𝑎 = ∆𝐻𝐻𝑎𝑎𝑎𝑎 − 𝑅𝑅𝛥𝛥𝑆𝑆𝑎𝑎𝑎𝑎  (6-2) In the case of EcPFK, it is the larger positive enthalpy term that determines the positive sign for the coupling free energy that defines inhibition.43,101 However, in 
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 BsPFK both of the components are negative, and it is the larger absolute value of the entropy term that drives inhibition.42 This suggests that fundamentally different mechanisms may be responsible for propagating the allosteric signal between PEP and Fru-6-P binding sites in these enzymes.  Both BsPFK and EcPFK are homotetrameric enzymes and each subunit contains a single tryptophan residue. In BsPFK, unlike EcPFK, the fluorescence intensity of the native tryptophan is not responsive to ligand binding.116 In Chapter II, a tryptophan-shifted mutant, F179W/W240F, was constructed to look at the allosteric coupling between Fru-6-P and PEP under equilibrium conditions. The variant’s kinetic and allosteric properties are similar to the wild-type enzyme as assessed by steady-state activity assays. Fortunately, the variant displays unique fluorescence properties that allow for the determination of dissociation constants for Fru-6-P and PEP in the absence of turnover. Using F179W/W240F, the extent of allosteric coupling between Fru-6-P and PEP was determined to be the same regardless of whether determined by steady-state kinetic or equilibrium  fluorescence techniques demonstrating that MgATP does not affect coupling between Fru-6-P and PEP. Fru-6-P was shown to bind substantially tighter in the absence of MgATP, which is the result of non-allosteric antagonistic effects at the active sites.69 The data presented in this chapter are in general agreement with previous studies in both BsPFK120 and EcPFK34,101 that validate the rapid equilibrium assumption for Fru-6-P, however some evidence is provided that this 
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 assumption may fall apart under conditions of low ATP concentration due to very tight binding.  Since ∆𝐺𝐺𝑎𝑎𝑎𝑎 conveys quantitatively both the nature and the magnitude of the allosteric effect, understanding the basis for inhibition in PFK involves understanding why the disproportionation equilibrium achieves its particular value. In this body of work, the enzyme was perturbed by both the denaturant urea and by “holes” engineered using site-directed mutagenesis and the effect on the poise of the equilibrium is accessed. In Chapter III the effect of urea on the allosteric coupling in PFK from EcPFK and BsPFK is examined. Both specific activity and the allosteric coupling increase at low urea concentrations in BsPFK, but not in EcPFK. Van’t Hoff analysis indicates that the increase in allosteric coupling is accompanied by a decrease in entropy-enthalpy compensation. The values for the entropy and enthalpy components of the coupling free energy indicate that at low concentrations of urea, 0.250 and 1 M, the increased coupling is the result of a larger change in the entropy component. At 4 M urea the trend of both of the entropy and enthalpy components decreasing continues, however the changes in coupling are dictated by the larger change in the enthalpy component. A possible explanation is that sub-dissociating concentrations of urea are stabilizing the tertiary structure of the enzyme, altering the conformational dynamics in BsPFK, but not so much the more flexible isoform EcPFK.  
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 Holes are introduced into the enzyme’s structure in the form of mutations that change particular isoleucines into valines in Chapter IV. We hypothesized that the addition of a small hole to the enzyme structure would not likely significantly alter the overall structure of the enzyme, but could allow for a change in the conformational entropy or flexibility of the enzyme in the effected region and possibly alter the allosteric coupling if the local region was involved in the transmission of the signal. Two of the three mutations had a significant effect on the coupling between Fru-6-P and PEP, one increasing and the other decreasing the allosteric coupling free energy. The strongest effect is an almost 4-fold augmentation of coupling in I153V-BsPFK. In this case there is decreased entropy-enthalpy compensation given a larger effect on the ΔHay component. An analogous mutation in EcPFK, L154V, has a minimal effect on the allosteric coupling in comparison. Methyl-TROSY NMR was used to obtain structural information on all four species of BsPFK that contribute to the poise of the disproportionation equilibrium shown above in Chapter V. As a result of the selective isotopic labeling, all 30 of the isoleucine residues per monomer contain one NMR visible methyl group in a Methyl-TROSY spectrum. Complementary HNCA and HN(CO)CA experiments with [U-15N,2H,13C]-BsPFK were used to assign the isoleucines in a 1H-15N TROSY spectrum. In order to transfer these assignments to the methyl-TROSY spectrum both 15N-edited and 13C-edited 3D -HMQC NOESY experiments were run with [U-
15N.2H];Ileδ1-[13CH3]-BsPFK. To distinguish chemical shift changes necessary for 
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 the allosteric regulation of BsPFK, it was essential to first establish the chemical shifts for each ligation state of the enzyme shown in the disproportionation equilibrium above. Fortunately, the ligand binding processes are in the fast exchange regime, allowing us to see resonances move across the field in response to the titration of ligand. Positions Ile-20, Ile-28, Ile-126, Ile-137, Ile-166 and Ile-176 possess the greatest difference in the comparison of chemical shifts between the ternary complex and the summation of the binary complexes. It is at these residues, where a conflict is experienced by the enzyme’s structure in response to the binding of both ligands simultaneously, that we predict the allosteric signal for inhibition is being transferred. Interestingly, these residues are dispersed throughout the enzyme as opposed to forming a single discrete pathway. As mentioned above, there is evidence for fundamentally different mechanisms for the coupling between binding sites in BsPFK and EcPFK, as indicated by contrasting thermodynamic driving forces. Conceivably, altering the conformational dynamics would not necessarily have the same effect on both enzymes. Both experiments at low concentrations of urea, and the hole mutant studies indicate that the coupling entropy and enthalpy that define the allosteric coupling free energy are very sensitive to even mild perturbations. This does not seem to be the case for the less rigid EcPFK, indicating that the allosteric coupling may be more “tunable” in BsPFK.  When Methyl-TROSY NMR was used to probe structural changes throughout the enzyme that relate to allosteric coupling, it was shown that in BsPFK there is 
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 APPENDIX: NOMENCLATURE  A Substrate  ATCase Aspartate transcarbamoylase  ATP Adenosine triphosphate  ADP Adenosine diphosphate  BsPFK Phosphofructokinase from Bacillus stearothermophilus   
ΔCp Change in heat capacity  CaM Calmodulin  cAMP Cyclic AMP  CAP Catabolite activator protein  CBP CREB binding protein  ClpP Caseinolytic protease  Da Daltons  DNA Deoxyribonucleic acid  dNTPs Deoxynucleotide triphosphates  DTT Dithiothreitol  E Enzyme  [E]t Total enzyme concentration  EcPFK Phosphofructokinase from Escherichia coli  EAM Ensemble allosteric model  EDTA Ethylenediamine tetraacetic acid 
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  EPPES N- [2-hydroxyethyl] piperazine--3-propanesulfonic acid  FPLC Fast protein liquid chromatography  Fru-2,6-BP Fructose-2,6-bisphosphate  Fru-6-P Fructose-6-phosphate 
 
ΔGay Coupling free energy for the binding of substrate and effector    
ΔHay Coupling enthalpy for the binding of substrate and effector  HMQC Heteronuclear multiple quantum coherence  ITC Isothermal calorimetry   kcat Turnover number  Ka Apparent dissociation constant for substrate A  Kia° Dissociation constant for A in the absence of effector  Kia∞ Dissociation constant for A in presence of saturating effector  Kiy° Dissociation constant for Y in the absence of substrate  Kiy∞ Dissociation constant for Y in presence of saturating substrate  Km Michaelis constant  KNF Sequential model  LB Lysogeny broth  LbPFK Phosphofructokinase from Lactobacillus delbrueckii ssp.  
 Bulgaricus  MES 2-(N-morpholino)ethanesulfonic acid  MLL Mixed lineage leukemia  
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 MSD Mean square deviations  MWC Concerted model  NADH Nicotinamide adenine dinucleotide, reduced form  
𝑅𝑅𝐻𝐻  Hill number  NMR Nuclear magnetic resonance  NOESY Nuclear overhauser effect spectroscopy  Pi Phosphate  PBD Pre-protein binding domain  PEP Phospo-(enol)pyruvate  PFP Pyrophosphate-fructose-6-phosphate-phosphotransferase  PFK or PFK-1 Phosphofructokinase-1  PFK-2 Phosphofructokinase-2  PPi Pyrophosphate  PRE Paramagnetic relaxation enhancement  Qaa Coupling constant for the binding of two substrates (K-type)   Qay Coupling constant for the binding of the substrate and effector   (K-type) 
 
ΔSay Coupling entropy for the binding of substrate and effector  SDS-PAGE Sodium sodecyl sulfate polyacrylaAmide gel electrophoresis  SecA Type II secretory pathway protein A  TROSY Transverse relaxation optimized spectroscopy  TtPFK Phosphofructokinase from Thermus thermophilus  
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 𝑣𝑣 Initial velocity  V° maximal activity in the absence of effector  V∞ maximal activity in the presence of saturating effector  Way Coupling constant for the binding of the substrate and effector   (V-type)  WT Wild-type  Y Effector  
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